BayCom (BCML) 10-Q/A 25 Jul 23 2022 Q1 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 12, 2022
Cover [Abstract]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-38483
Entity Registrant Name	BAYCOM CORP
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	37-1849111
Entity Address, Address Line One	500 Ygnacio Valley Road
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Walnut Creek
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94596
City Area Code	925
Local Phone Number	476-1800
Title of 12(b) Security	Common Stock, no par value per share
Trading Symbol	BCML
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		13,579,114
Entity Central Index Key	0001730984
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	true
Amendment Description	EXPLANATORY NOTE REGARDING RESTATEMENT BayCom, a California corporation, is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022 ("Amended Report") to reflect a restatement of the consolidated financial statements contained in the Company's original Quarterly Report on Form 10-Q for that period filed with the Securities and Exchange Commission ("SEC") on May 16, 2022 (the "Original Report"). Restatement of Previously Issued Consolidated Financial Statements On July 18, 2023, the audit committee of the Company's board of directors concluded that the Company's previously issued consolidated financial statements for the interim period ended March 31, 2023 and year ended December 31, 2022, as well as for the interim periods included in that fiscal year, should no longer be relied upon because of errors related to the accounting for unrealized losses on preferred equity securities that resulted in material misstatements of noninterest income and accumulated other comprehensive income. At the time of its purchase of the preferred equity securities for investment purposes, the Company inappropriately accounted for them as available for sale debt securities under Accounting Standards Codification ("ASC") Topic 320 – Investments-Debt Securities. As such, the changes in the fair value of these securities were not recorded as part of net income but rather as a component of shareholders' equity (in accumulated other comprehensive income, net of tax). However, as a result of subsequent research and third-party consultation, the Company determined that the securities should instead have been accounted for under ASC Topic 321 – Investments-Equity Securities. The result of this change in classification of the preferred equity securities is that the change in the fair value of the securities each quarter should have been recorded in noninterest income on the consolidated statements of income. As disclosed in the Original Report, the Company recorded the change, net of taxes, in the fair value of preferred equity securities totaling $1.3 million for the three months ended March 31, 2022 as part of Other Comprehensive loss, net of taxes, under ASC Topic 320 – Investments-Debt Securities rather than as part of non-interest income under ASC Topic 321 – Investments-Equity Securities. For additional information on the restatement, see Note 3 Restatement of Previously Issued Consolidated Financial Statements in the Notes to Condensed Consolidated Financial Statements contained in Part I, Item 1 of this Amended Report. Items Amended in this Filing We are filing this Amended Report in order to amend the following items of the Original Report to the extent necessary to reflect the adjustments discussed above and make corresponding revisions to the financial data appearing elsewhere in the Original Report: • Part I, Item 1. Financial Statements • Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations • Part I, Item 4. Controls and Procedures Except as indicated above, no other information in the Original Report is amended hereby. In order to preserve the nature and character of the disclosures set forth in the Original Report, except as expressly noted above, this Amended Report speaks as of the date of the filing of the Original Report, and we have not updated the disclosures in this Amended Report to speak as of a later date. All information contained in this Amended Report is subject to updating and supplementing as provided in filings with the SEC subsequent to the filing date of the Original Report. Accordingly, this Amended Report should be read in conjunction with our filings made with the SEC subsequent to the filing date of the Original Report Control Considerations In connection with the above, our management has reassessed the effectiveness of our disclosure controls and procedures as of March 31, 2022, and we have included applicable disclosure in Part I, Item 4 herein, "Controls and Procedures." Management identified a material weakness in our internal control over financial reporting, as described in Part I, Item 4 of this Amended Report, resulting in the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures were not effective as of March 31, 2022. Management has taken steps, and is continuing to take steps, to remediate this material weakness, as described under "Remediation Plan and Status" in Part I, Item 4 of this Amended Report.

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash due from banks	$ 35,532	$ 21,178
Federal funds sold and interest-bearing balances in banks	391,667	358,509
Cash and cash equivalents	427,199	379,687
Time deposits in banks	3,336	3,585
Investment securities available-for-sale (AFS)	167,975	155,658
Equity securities	16,698	18,777
Federal Home Loan Bank ("FHLB") stock, at par	10,679	8,385
Federal Reserve Bank ("FRB") stock, at par	8,547	7,650
Loans held for sale	970	6,470
Loans, net of allowance for credit losses	1,986,228	1,647,190
Premises and equipment, net	14,257	14,370
Other real estate owned ("OREO")	21	21
Core deposit intangible, net	6,750	6,489
Cash surrender value of bank owned life insurance ("BOLI") policies, net	21,736	21,590
Right-of-use assets ("ROU"), net	13,645	12,127
Goodwill	38,838	38,838		$ 38,838
Interest receivable and other assets	39,133	29,860
Total assets	2,756,012	2,350,697
LIABILITIES AND SHAREHOLDERS' EQUITY
Noninterest and interest bearing deposits	2,330,395	1,985,239
Junior subordinated deferrable interest debentures, net	8,423	8,403
Subordinated debt, net	63,584	63,542
Salary continuation plan	4,517	4,393
Lease liabilities	14,177	12,657
Interest payable and other liabilities	10,262	13,856
Total liabilities	2,431,358	2,088,090
Commitments and contingencies (Note 19)
Shareholders' equity
Preferred stock
Common stock	220,294	157,098
Additional paid in capital	287	287
Accumulated other comprehensive loss, net of tax	(3,527)	2,166
Retained earnings	107,600	103,056
Total shareholders' equity	324,654	262,607	$ 254,550	$ 252,591
Total liabilities and shareholders' equity	$ 2,756,012	$ 2,350,697

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Allowance for loan losses
Investment securities available-for-sale amortized cost	$ 172,927	$ 153,062
Allowance for loan losses	$ 17,700	$ 17,700	$ 17,500	$ 17,500
Preferred Stock
Preferred Stock, No Par Value	$ 0	$ 0
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock
Common Stock, No Par Value	$ 0	$ 0
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	13,677,729	10,680,386
Common Stock, Shares, Outstanding	13,677,729	10,680,386

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest income:
Loans, including fees	$ 22,927	$ 19,193
Investment securities	1,608	868
FHLB dividends	149	99
FRB dividends	121	112
Total interest and dividend income	24,805	20,272
Interest expense:
Deposits	1,470	1,206
Subordinated debt	896	895
Junior subordinated debt	86	87
Total interest expense	2,452	2,188
Net interest income	22,353	18,084
Provision for credit losses	7	0
Net interest income after provision for credit losses	22,346	18,084
Noninterest income:
Gain on sale of loans	1,137	576
Loss on equity securities	(1,768)
Loan servicing and other loan fees	574	529
Income on investment in Small Business Investment Company ("SBIC") fund	197	263
Gain on sale of OREO		36
Bargain purchase gain	1,665
Other income and fees	196	229
Total noninterest income	2,631	2,237
Noninterest expense:
Salaries and employee benefits	10,310	8,885
Occupancy and equipment	2,426	1,815
Data processing	2,273	1,484
Other expense	3,312	1,901
Total noninterest expense	18,321	14,085
Income before provision for income taxes	6,656	6,236
Provision for income taxes	1,427	1,704
Net income	$ 5,229	$ 4,532
Earnings per common share:
Basic earnings per common share (in dollars per share)	$ 0.41	$ 0.40
Weighted average shares outstanding (in shares)	12,646,981	11,273,604
Diluted earnings per common share (in dollars per share)	$ 0.41	$ 0.40
Weighted average shares outstanding (in shares)	12,646,981	11,273,604
Service charges and other fees
Noninterest income:
Service charges and other fees	$ 630	$ 604

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net income
Net income	$ 5,229	$ 4,532
Other comprehensive loss:
Change in unrealized loss on available-for-sale securities	(7,993)	(1,101)
Deferred tax benefit	2,300	316
Other comprehensive loss, net of tax	(5,693)	(785)
Total comprehensive income (loss)	$ (464)	$ 3,747

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income/(Loss)	Retained Earnings	Total
Balance at Dec. 31, 2020	$ 167,242	$ 287	$ 2,697	$ 82,365	$ 252,591
Balance (in shares) at Dec. 31, 2020	11,295,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income				4,532	4,532
Other comprehensive loss, net			(785)		(785)
Restricted stock granted (in shares)	24,187
Stock based compensation	$ 413				413
Repurchase of shares	$ (2,201)				(2,201)
Repurchase of shares (in shares)	(132,123)
Balance at Mar. 31, 2021	$ 165,454	287	1,912	86,897	254,550
Balance (in shares) at Mar. 31, 2021	11,187,461
Balance at Dec. 31, 2021	$ 157,098	287	2,166	103,056	$ 262,607
Balance (in shares) at Dec. 31, 2021	10,680,386				10,680,386
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income				5,229	$ 5,229
Other comprehensive loss, net			(5,693)		(5,693)
Restricted stock granted (in shares)	22,473
Restricted stock forfeited (in shares)	(532)
Issuance of common shares to acquire Pacific Enterprise Bancorp	$ 64,140				64,140
Issuance of common shares to acquire Pacific Enterprise Bancorp (in shares)	3,032,579
Cash dividends declared on common stock				(685)	(685)
Stock based compensation	$ 324				324
Repurchase of shares	$ (1,268)				(1,268)
Repurchase of shares (in shares)	(57,177)
Balance at Mar. 31, 2022	$ 220,294	$ 287	$ (3,527)	$ 107,600	$ 324,654
Balance (in shares) at Mar. 31, 2022	13,677,729				13,677,729

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)	3 Months Ended
	Mar. 31, 2022 $ / shares
Stock Transactions, Parenthetical Disclosures [Abstract]
Cash dividends (in dollars per share)	$ 0.05

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 5,229	$ 4,532
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	7	0
Increase in deferred tax assets	2,309	(29)
Accretion on acquired loans	(231)	(642)
Gain on sale of loans	(1,137)	(576)
Proceeds from sale of loans	10,936	6,800
Loans originated for sale	(7,931)	(9,702)
Loss on sale of premises, net		(12)
Gain on sale of OREO		(36)
Bargain purchase gain	(1,665)
Accretion on junior subordinated debentures	20	21
Increase in cash surrender value of life insurance policies	(146)	(165)
Amortization/accretion of premiums/discounts on investment securities, net	137	109
Loss on equity securities	1,768
Depreciation and amortization	486	520
Core deposit intangible amortization	495	454
Stock based compensation expense	325	413
Decrease in deferred loan origination fees, net	(1,362)	798
Increase (decrease) in interest receivable and other assets	(432)	(2,768)
Increase in salary continuation plan, net	124	91
Decrease in interest payable and other liabilities	(6,086)	843
Net cash provided by operating activities	2,846	651
Cash flows from investing activities:
Proceeds from maturities of interest bearing deposits in banks	249	998
Purchase of investment securities	(22,671)	(4,438)
Proceeds from the maturities, repayments and calls of investment securities	2,475	7,420
Proceeds from the sales of investment securities	63
(Redemption) purchase of Federal Reserve Bank stock	45	(12)
(Decrease) increase in loans, net	79,031	66,490
Proceeds from sale of premises		46
Proceeds from sale of OREO	22	279
Purchase of equipment and leasehold improvements, net	(174)	(397)
Net cash received for acquisitions	18,423
Net cash (used in) provided by investing activities	77,463	70,386
Cash flows from financing activities:
(Decrease) increase in noninterest and interest bearing deposits	293,572	96,513
Increase (decrease) in time deposits, net	(325,101)	(6,939)
Repurchase of common stock	(1,268)	(2,201)
Net cash provided by (used in) financing activities	(32,797)	87,373
Increase in cash and cash equivalents	47,512	158,410
Cash and cash equivalents at beginning of period	379,687	299,329	$ 299,329
Cash and cash equivalents at end of period	427,199	457,739	$ 379,687
Cash paid during the year for:
Interest expense	3,306	2,221
Cash paid during the year for:
Income taxes paid, net	6,985	33
Non-cash investing and financing activities:
Change in unrealized loss on available-for-sale securities, net of tax	(5,693)	(785)
Recognition of ROU assets		832
Recognition of lease liability		$ 833
Acquisition:
Assets acquired, net of cash received	440,785
Liabilities assumed	380,055
Common stock issued	$ 64,140

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
BASIS OF PRESENTATION	NOTE 1 – BASIS OF PRESENTATION BayCom Corp (the “Company”) is a bank holding company headquartered in Walnut Creek, California. United Business Bank (the “Bank”), the Company’s wholly owned banking subsidiary, is a California state-chartered bank which provides a broad range of financial services primarily to local small and mid-sized businesses, service professionals and individuals. In the 17 years of operation, the Bank has grown to 34 full-service banking branches with 16 locations in California, two in Washington, five in Central New Mexico and 11 in Colorado. The condensed consolidated financial statements include the accounts of the Company and the Bank. All intercompany transactions and balances have been eliminated in consolidation. The condensed consolidated financial statements include all adjustments of a normal and recurring nature, which are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations for the periods presented. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all information and footnotes normally included in annual financial statements prepared in conformity with accounting principles generally accepted in the United States of America. Accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Results of operations for interim periods are not necessarily indicative of results for the full year. Certain prior year information has been reclassified to conform to the current year presentation. None of the reclassifications impacted consolidated net income, earnings per share or shareholders’ equity. On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for qualifying public companies. As an “emerging growth company” we may delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We intend to take advantage of the benefits of this extended transition period. Accordingly, our condensed consolidated financial statements may not be comparable to companies that comply with such new or revised accounting standards. On February 1, 2022, the Company completed its acquisition of Pacific Enterprise Bancorp (“PEB”) and its wholly owned subsidiary of Pacific Enterprise Bank, headquartered in Irvine, California (“PEB Merger”). See “Note 4 – Acquisitions” for additional information on the PEB Merger.

ACCOUNTING GUIDANCE NOT YET EFF

ACCOUNTING GUIDANCE NOT YET EFFECTIVE AND ADOPTED ACCOUNTING GUIDANCE	3 Months Ended
	Mar. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
ACCOUNTING GUIDANCE NOT YET EFFECTIVE AND ADOPTED ACCOUNTING GUIDANCE	NOTE 2 - ACCOUNTING GUIDANCE NOT YET EFFECTIVE AND ADOPTED ACCOUNTING GUIDANCE Recent Accounting Guidance Not Yet Effective In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and subsequent amendments to the initial guidance in November 2018, ASU No. 2018-19, April 2019, ASU 2019-04, May 2019, ASU 2019-05, November 2019, ASU 2019-11, February 2020, ASU 2020-02, and March 2020, ASU 2020-03, all of which clarifies codification and corrects unintended application of the guidance. ASU 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. In issuing the standard, the FASB is responding to criticism that today’s guidance delays recognition of credit losses. The standard will replace today’s “incurred loss” approach with an “expected loss” model. The new model, referred to as the current expected credit loss (“CECL”) model, will apply to: (1) financial assets subject to credit losses and measured at amortized cost, and (2) certain off-balance sheet credit exposures. This includes, but is not limited to, loans, leases, held-to-maturity securities, loan commitments, and financial guarantees. The CECL model does not apply to available-for-sale (“AFS”) debt securities. For AFS debt securities with unrealized losses, entities will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than reductions in the amortized cost of the securities. As a result, entities will recognize improvements to estimated credit losses immediately in earnings rather than as interest income over time, as they do today. The ASU also simplifies the accounting model for purchased credit-impaired (“PCI”) debt securities and loans. ASU 2016-13 also expands the disclosure requirements regarding an entity’s assumptions, models, and methods for estimating the allowance for loan and lease losses. In addition, public business entities will need to disclose the amortized cost balance for each class of financial asset by credit quality indicator, disaggregated by the year of origination. ASU 2018-19 clarifies that receivables arising from operating leases are accounted for using lease guidance and not as financial instruments. ASU 2019-04, “Codification Improvements to Topic 326, Financial Instruments — Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. ASU 2019-05 allows entities to irrevocably elect, upon adoption of ASU 2016-13, the fair value option on financial instruments that (1) were previously recorded at amortized cost and (2) are within the scope of ASC 326-20 if the instruments are eligible for the fair value option under ASC 825-10. The fair value option election does not apply to held-to-maturity debt securities. Entities are required to make this election on an instrument-by-instrument basis. The amendments in these ASUs are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with early adoption permitted for smaller reporting companies, such as the Company. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., modified retrospective approach). The Company is reviewing the requirements of these ASUs and expects to begin developing and implementing processes and procedures to ensure it is fully compliant with the amendments at the adoption date. Upon adoption, the Company expects changes in the processes and procedures used to calculate the allowance for loan losses, including changes in assumptions and estimates to consider expected credit losses over the life of the loan versus the current accounting practice that utilizes the incurred loss model. The new guidance may result in an increase in the allowance for loan losses which will also reflect the new requirement to include the nonaccretable principal differences on purchased credit-impaired loans; however, the Company is still in the process of determining the magnitude of the change and its impact on the Company's consolidated financial statements. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of reference Rate Reform on Financial Reporting In March 2022 the FASB issued ASU 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures

RESTATEMENT OF THE CONSOLIDATED

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS	3 Months Ended
	Mar. 31, 2022
Prior Period Adjustment [Abstract]
RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS	NOTE 3 – RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS On July 18, 2023, the audit committee of the Company’s board of directors concluded that the Company’s previously issued unaudited interim consolidated financial statements for the period ended March 31, 2023 and the consolidated financial statements for the year ended December 31, 2022, as well as for the unaudited interim periods included in that fiscal year, should no longer be relied upon because of errors related to the accounting for unrealized losses on preferred equity securities that resulted in material misstatements of noninterest income and accumulated other comprehensive income. ​ At the time of its purchase of the preferred equity securities for investment purposes, the Company inappropriately accounted for them as available for sale debt securities under Accounting Standards Codification (“ASC”) Topic 320 – Investments-Debt Securities Investments-Equity Securities ​ As disclosed in the Original Report, the Company recorded the change, net of taxes, in the fair value of preferred equity securities totaling $1.3 million for the three months ended March 31, 2022 as part of Other Comprehensive loss, net of taxes, under ASC Topic 320 – Investments-Debt Securities Investments-Equity Securities ​ In addition to the below, various footnotes reflect the effects of these restatements including, but not limited to, Note 4, Acquisitions and Note 5, Investment Securities. ​ The tables below show the effects of the restatement on the Company’s condensed consolidated balance sheets, condensed consolidated statements of income, condensed consolidated statements of comprehensive loss, condensed consolidated statements of changes in shareholders’ equity, and condensed consolidated statement of cash flows as of and for the quarter ended March 31, 2022 (in thousands, except for per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 Consolidated Balance Sheet ​ (As Previously Reported) Adjustments (As Restated) ASSETS ​ ​ ​ Cash and due from banks ​ $ 35,532 $ — $ 35,532 Federal funds sold ​ 391,667 — 391,667 Cash and cash equivalents ​ ​ 427,199 ​ — ​ 427,199 Interest bearing deposits in banks ​ ​ 3,336 ​ — ​ 3,336 Investment securities available-for-sale ​ ​ 184,673 ​ (16,698) ​ 167,975 Equity securities ​ ​ — ​ 16,698 ​ 16,698 Federal Home Loan Bank ("FHLB") stock, at par ​ ​ 10,679 ​ — ​ 10,679 Federal Reserve Bank ("FRB") stock, at par ​ ​ 8,547 ​ — ​ 8,547 Loans held for sale ​ ​ 970 ​ — ​ 970 Loans, net of allowance for loan losses of $17,700 at March 31, 2022 and $17,700 December 31, 2021 ​ ​ 1,986,228 ​ — ​ 1,986,228 Premises and equipment, net ​ ​ 14,257 ​ — ​ 14,257 Other real estate owned ("OREO") ​ ​ 21 ​ — ​ 21 Core deposit intangible, net ​ ​ 6,750 ​ — ​ 6,750 Cash surrender value of bank owned life insurance ("BOLI") policies, net ​ ​ 21,736 ​ — ​ 21,736 Right-of-use assets ("ROU"), net ​ ​ 13,645 ​ — ​ 13,645 Goodwill ​ ​ 38,838 ​ — ​ 38,838 Interest receivable and other assets ​ ​ 39,133 ​ — ​ 39,133 Total assets ​ $ 2,756,012 $ — $ 2,756,012 LIABILITIES AND SHAREHOLDERS’ EQUITY ​ ​ ​ ​ Noninterest and interest bearing deposits ​ $ 2,330,395 $ — $ 2,330,395 Junior subordinated deferrable interest debentures, net ​ 8,423 — 8,423 Subordinated debt, net ​ ​ 63,584 ​ — ​ 63,584 Salary continuation plan ​ 4,517 — 4,517 Lease liabilities ​ 14,177 — 14,177 Interest payable and other liabilities ​ 10,262 — 10,262 Total liabilities ​ 2,431,358 — 2,431,358 Commitments and contingencies (Note 19) ​ Shareholders' equity ​ Preferred stock, no par value; 10,000,000 shares authorized; no shares issued and outstanding at both March 31, 2022 and December 31, 2021 ​ — — — Common stock, no par value; 100,000,000 shares authorized; 13,677,729 and 10,680,386 shares issued outstanding ​ 220,294 — 220,294 Additional paid in capital ​ 287 — 287 Accumulated other comprehensive loss, net of tax ​ (4,786) 1,259 (3,527) Retained earnings ​ 108,859 (1,259) 107,600 Total shareholders’ equity ​ 324,654 — 324,654 Total liabilities and shareholders’ equity ​ $ 2,756,012 $ — $ 2,756,012 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Income (As Previously Reported) ​ Adjustments ​ (As Restated) Interest income: ​ ​ ​ ​ ​ ​ ​ ​ ​ Loans, including fees ​ $ 22,927 ​ $ — ​ $ 22,927 Investment securities and interest bearing deposits in banks ​ 1,608 ​ — ​ 1,608 FHLB dividends ​ 149 ​ — ​ 149 FRB dividends ​ 121 ​ — ​ 121 Total interest and dividend income ​ 24,805 ​ — ​ 24,805 Interest expense: ​ ​ ​ Deposits ​ 1,470 ​ — ​ 1,470 Subordinated debt ​ ​ 896 ​ ​ — ​ ​ 896 Other borrowings ​ 86 ​ — ​ 86 Total interest expense ​ 2,452 ​ — ​ 2,452 Net interest income ​ 22,353 ​ — ​ 22,353 Provision for loan losses ​ 7 ​ — ​ 7 Net interest income after provision for loan losses ​ 22,346 ​ — ​ 22,346 Noninterest income: ​ ​ ​ Gain on sale of loans ​ 1,137 ​ — ​ 1,137 Loss on equity securities ​ ​ — ​ ​ (1,768) ​ ​ (1,768) Service charges and other fees ​ 630 ​ — ​ 630 Loan servicing and other loan fees ​ 574 ​ — ​ 574 Income on investment in Small Business Investment Company (“SBIC”) fund ​ 197 ​ — ​ 197 Bargain purchase gain ​ ​ 1,665 ​ ​ — ​ ​ 1,665 Other income and fees ​ 196 ​ — ​ 196 Total noninterest income ​ 4,399 ​ (1,768) ​ 2,631 Noninterest expense: ​ ​ ​ Salaries and employee benefits ​ 10,310 ​ — ​ 10,310 Occupancy and equipment ​ 2,426 ​ — ​ 2,426 Data processing ​ 2,273 ​ — ​ 2,273 Other expense ​ 3,312 ​ — ​ 3,312 Total noninterest expense ​ 18,321 ​ — ​ 18,321 Income before provision for income taxes ​ 8,424 ​ (1,768) ​ 6,656 Provision for income taxes ​ 1,936 ​ (509) ​ 1,427 Net income ​ $ 6,488 ​ $ (1,259) ​ $ 5,229 Earnings per common share: ​ ​ ​ Basic earnings per common share ​ $ 0.51 ​ $ (0.10) ​ $ 0.41 Weighted average shares outstanding ​ 12,646,981 ​ 12,646,981 ​ 12,646,981 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Comprehensive Loss ​ (As Previously Reported) ​ Adjustments ​ (As Restated) Net income ​ $ 6,488 ​ $ (1,259) ​ $ 5,229 Other comprehensive loss: ​ ​ ​ ​ ​ ​ Change in unrealized loss on available-for-sale securities ​ (9,761) ​ 1,768 ​ (7,993) Deferred tax benefit ​ 2,809 ​ (509) ​ 2,300 Other comprehensive loss, net of tax ​ (6,952) ​ 1,259 ​ (5,693) Total comprehensive loss ​ $ (464) ​ $ — ​ $ (464) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Cash Flow Changes (As Previously Reported) ​ Adjustments ​ (As Restated) Cash flows from operating activities: ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 6,488 ​ ​ (1,259) ​ ​ 5,229 Adjustments to reconcile net income to net cash provided by operating activities: ​ ​ ​ ​ ​ Decrease in deferred tax assets ​ 2,818 ​ ​ (509) ​ ​ 2,309 Loss on equity securities ​ ​ — ​ ​ 1,768 ​ ​ 1,768 Net cash provided by operating activities ​ 2,846 ​ ​ — ​ ​ 2,846 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash investing and financing activities: ​ ​ ​ Change in unrealized loss on available-for-sale securities, net of tax ​ $ (6,952) ​ $ 1,259 ​ $ (5,693) ​

ACQUISITIONS

ACQUISITIONS	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
ACQUISITIONS	NOTE 4 – ACQUISITIONS Acquisition of Pacific Enterprise Bancorp (“PEB”) On February 1, 2022, the Company completed the PEB Merger. As of the acquisition date, PEB merged into the Company and Pacific Enterprise Bank, PEB’s wholly owned bank subsidiary, merged into United Business Bank. The acquisition expanded the Company’s market share in California with one branch in Irvine. Pursuant to the merger agreement, at the effective time of the PEB Merger, BayCom paid aggregate consideration to PEB shareholders of approximately $64.1 million consisting of 3,032,579 shares of BayCom common stock and $275,000 in cash. Noninterest income for the current quarter included $1.6 million in bargain purchase gain, offset by $3.1 million of nonrecurring acquisition-related expenses included in noninterest expense related to the Company’s acquisition of PEB. The following table summarizes the fair value of the assets acquired and liabilities assumed at the acquisition date: ​ ​ ​ ​ ​ ​ ​ PEB ​ ​ Acquisition ​ ​ ​ Date ​ ​ ​ February 1, 2022 ​ Fair value of assets: ​ Cash and due from banks ​ $ 5,350 ​ Total cash and cash equivalents ​ 5,350 ​ ​ ​ ​ ​ ​ Interest bearing deposits in banks ​ 13,348 ​ Investment securities available-for-sale ​ ​ 3 ​ FHLB stock, at par ​ 2,294 ​ FRB stock, at par ​ 942 ​ Loans, net ​ 412,851 ​ Premises and equipment, net ​ ​ 221 ​ Core deposit intangible ​ 756 ​ Deferred tax assets, net ​ 1,192 ​ Interest receivable and other assets ​ ​ 9,178 ​ Total assets acquired ​ 446,135 ​ Liabilities: ​ ​ Deposits ​ ​ Noninterest bearing ​ 60,006 ​ Interest bearing ​ 316,679 ​ Total Deposits ​ 376,685 ​ ​ ​ ​ ​ ​ Interest payable and other liabilities ​ ​ 3,370 ​ Total liabilities assumed ​ ​ 380,055 ​ ​ ​ ​ ​ ​ Stock consideration ​ 64,140 ​ Cash consideration ​ 275 ​ Bargain purchase gain ​ $ 1,665 ​ ​ The following table presents the net assets acquired and the estimated fair value adjustments, which resulted in bargain purchase gain at the acquisition date: ​ ​ ​ ​ ​ ​ ​ PEB ​ ​ Acquisition ​ ​ ​ Date ​ ​ ​ February 1, 2022 ​ Book value of net assets acquired ​ $ 61,469 ​ Fair value adjustments: ​ ​ Loans, net ​ 5,840 ​ Premises and equipment, net ​ ​ 26 ​ Core deposit intangible ​ 756 ​ Time deposits ​ ​ (869) ​ Reserve for unfunded commitments ​ 283 ​ Write-up right-of-use asset ​ 439 ​ Total purchase accounting adjustments ​ 6,475 ​ ​ ​ ​ ​ ​ Tax effect of purchase accounting adjustments at 27.9% ​ (1,864) ​ Fair value of assets acquired ​ 66,080 ​ Value of stock issued/cash paid for stock options ​ 64,415 ​ Bargain purchase gain ​ $ (1,665) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pro Forma Results of Operations The operating results of the Company for the three months ended March 31, 2022 in the condensed consolidated statements of income include the operating results of PEB, since its acquisition date. The following table represents the net interest income, net income, basic and diluted earnings per share, as if the PEB Merger was effective January 1, 2021. The unaudited pro forma information in the following table is intended for informational purposes only and is not necessarily indicative of future operating results or operating results that would have occurred had the mergers been completed at the beginning of the respective years. No assumptions have been applied to the pro forma results of operation regarding possible revenue enhancements, expense efficiencies or asset dispositions. Unaudited pro forma net interest income, net income and earnings per share are presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, ​ ​ ​ ​ 2022 (As Restated) ​ ​ 2021 ​ Net interest income ​ $ 23,205 ​ $ 24,271 ​ Net income ​ 1,869 ​ 6,084 ​ Basic earnings per share ​ $ 0.14 ​ $ 0.42 ​ Diluted earnings per share ​ ​ 0.14 ​ ​ 0.42 ​ ​ These amounts include the third-party acquisition related-expenses, accretion of the discounts on acquired loans and amortization of the fair value mark adjustments on core deposit intangible. Acquisition expenses Acquisition expenses are recognized as incurred and continue until all systems are converted and operational functions become fully integrated. No third-party acquisition expenses were recognized in the consolidated statements of income for the three months ended March 31, 2021. The Company recognized third-party acquisition expenses for the three months ended March 31, 2022, as follows: ​ ​ ​ ​ ​ Severance expense $ 556 Occupancy expense ​ 375 Data processing ​ 1,073 Professional fees ​ ​ 724 Other expenses ​ 347 Total ​ $ 3,075 ​

INVESTMENT SECURITIES

INVESTMENT SECURITIES	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	NOTE 5 – INVESTMENT SECURITIES The amortized cost, gross unrealized gains and losses, and estimated fair values of investment securities available-for-sale at the dates indicated are summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ ​ cost ​ gains ​ losses ​ fair value March 31, 2022 (As Restated) ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,509 ​ $ — ​ $ (1) ​ $ 1,508 ​ Municipal securities ​ 23,541 ​ 56 ​ (1,066) ​ 22,531 ​ Mortgage-backed securities ​ 36,445 ​ 323 ​ (1,474) ​ 35,294 ​ Collateralized mortgage obligations ​ 30,602 ​ 96 ​ (1,277) ​ 29,421 ​ SBA securities ​ 5,680 ​ 36 ​ (64) ​ 5,652 ​ Corporate bonds ​ 75,150 ​ 356 ​ (1,937) ​ 73,569 ​ Total ​ $ 172,927 ​ $ 867 ​ $ (5,819) ​ $ 167,975 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ ​ cost ​ gains ​ losses ​ fair value December 31, 2021 ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,510 ​ $ — ​ $ — ​ $ 1,510 Municipal securities ​ 23,646 ​ 493 ​ (16) ​ 24,123 Mortgage-backed securities ​ 33,973 ​ 1,333 ​ (210) ​ 35,096 Collateralized mortgage obligations ​ 27,228 ​ 436 ​ (158) ​ 27,506 SBA securities ​ 6,055 ​ 53 ​ (20) ​ 6,088 Corporate bonds ​ 60,650 ​ 851 ​ (166) ​ 61,335 Total ​ $ 153,062 ​ $ 3,166 ​ $ (570) ​ $ 155,658 ​ ​ During the three months ended March 31, 2022, the Company sold one available-for-sale securities for minimal realized gains and did not ​ The estimated fair value and gross unrealized losses for securities available-for-sale aggregated by the length of time that individual securities have been in a continuous unrealized loss position at the dates indicated are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Less than 12 months ​ 12 months or more ​ Total ​ Estimated Unrealized Estimated Unrealized Estimated Unrealized ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss March 31, 2022 (As Restated) ​ ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,508 ​ $ (1) ​ $ — ​ $ — ​ $ 1,508 ​ $ (1) Municipal securities ​ ​ 14,198 ​ ​ (1,066) ​ ​ — ​ ​ — ​ ​ 14,198 ​ ​ (1,066) Mortgage-backed securities ​ ​ 18,877 ​ ​ (1,076) ​ ​ 2,740 ​ ​ (398) ​ ​ 21,617 ​ ​ (1,474) Collateralized mortgage obligations ​ 18,474 ​ ​ (1,092) ​ ​ 2,059 ​ ​ (185) ​ 20,533 ​ (1,277) SBA securities ​ 1,194 ​ ​ (44) ​ ​ 976 ​ ​ (20) ​ 2,170 ​ (64) Corporate bonds ​ 50,313 ​ ​ (1,937) ​ ​ — ​ ​ — ​ 50,313 ​ (1,937) Total ​ $ 104,564 ​ $ (5,216) ​ $ 5,775 ​ $ (603) ​ $ 110,339 ​ $ (5,819) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Less than 12 months ​ 12 months or more ​ Total ​ Estimated Unrealized Estimated Unrealized Estimated Unrealized ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss December 31, 2021 ​ ​ ​ ​ ​ ​ ​ Municipal securities ​ $ 3,932 ​ $ (16) ​ $ — ​ $ — ​ $ 3,932 ​ $ (16) Mortgage-backed securities ​ 2,954 ​ (111) ​ 2,133 ​ (99) ​ 5,087 ​ (210) Collateralized mortgage obligations ​ 9,236 ​ (108) ​ 1,605 ​ (50) ​ 10,841 ​ (158) SBA securities ​ 134 ​ — ​ 1,058 ​ (20) ​ 1,192 ​ (20) Corporate bonds ​ 23,084 ​ (166) ​ — ​ — ​ 23,084 ​ (166) Total ​ $ 39,340 ​ $ (401) ​ $ 4,796 ​ $ (169) ​ $ 44,136 ​ $ (570) ​ At March 31, 2022, the Company held 330 investment securities, of which 20 were in an unrealized loss position for more than twelve months and 145 were in an unrealized loss position for less than twelve months. These temporary unrealized losses relate principally to current interest rates for similar types of securities. The Company anticipates full recovery of amortized cost with respect to these securities at maturity or sooner in the event of a more favorable market interest rate environment. The amortized cost and estimated fair value of securities available-for-sale at the dates indicated by contractual maturity are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 ​ December 31, 2021 ​ Amortized Estimated Amortized Estimated ​ ​ cost ​ fair value ​ cost ​ fair value ​ ​ (As Restated) ​ (As Restated) ​ ​ ​ ​ ​ ​ Available-for-sale ​ ​ ​ ​ Due in one year or less ​ $ 861 ​ $ 861 ​ $ 862 ​ $ 865 Due after one through five years ​ 23,297 ​ 23,229 ​ 23,519 ​ 24,173 Due after five years through ten years ​ 88,707 ​ 85,952 ​ 79,116 ​ 79,993 Due after ten years ​ 60,062 ​ 57,933 ​ 49,565 ​ 50,627 Total ​ $ 172,927 ​ $ 167,975 ​ $ 153,062 ​ $ 155,658 ​ Equity securities months ended March 31, 2021. Equity securities were $16.7 million as of March 31, 2022, compared to $18.8 million as of December 31, 2021.

LOANS

LOANS	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
LOANS	NOTE 6 – LOANS The Company’s loan portfolio at the dates indicated is summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Commercial and industrial ​ $ 313,556 ​ $ 230,177 Construction and land ​ 20,854 ​ 13,371 Commercial real estate ​ 1,564,305 ​ 1,299,684 Residential ​ 102,079 ​ 118,423 Consumer ​ 3,675 ​ 5,138 Total loans ​ 2,004,469 ​ 1,666,793 Net deferred loan fees ​ (541) ​ (1,903) Allowance for loan losses ​ (17,700) ​ (17,700) Net loans ​ $ 1,986,228 ​ $ 1,647,190 ​ During the first quarter of 2022, the Bank continued its participation in the U.S. Small Business Administration (“SBA”) Paycheck Protection Program (“PPP”), by processing applications for PPP loan forgiveness. ​ The Company’s total impaired loans, including nonaccrual loans TDR loans, and accreting purchase credit impaired (“PCI”) loans that have experienced post-acquisition declines in cash flows expected to be collected are summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial Construction Commercial ​ ​ ​ ​ ​ and industrial ​ and land ​ real estate ​ Residential ​ Consumer ​ Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ Recorded investment in impaired loans: ​ ​ ​ ​ ​ ​ With no specific allowance recorded ​ $ 184 ​ $ 36 ​ $ 5,451 ​ $ 1,632 ​ $ — ​ $ 7,303 With a specific allowance recorded ​ 5,538 ​ — ​ 259 ​ 128 ​ — ​ 5,925 Total recorded investment in impaired loans ​ $ 5,722 ​ $ 36 ​ $ 5,710 ​ $ 1,760 ​ $ — ​ $ 13,228 Specific allowance on impaired loans ​ $ 1,277 ​ $ — ​ $ 259 ​ $ 10 ​ $ — ​ 1,546 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ ​ ​ ​ Recorded investment in impaired loans: ​ ​ ​ ​ ​ ​ With no specific allowance recorded ​ $ 112 ​ $ 36 ​ $ 5,015 ​ $ 1,441 ​ $ — ​ $ 6,604 With a specific allowance recorded ​ 681 ​ — ​ 262 ​ 146 ​ — ​ 1,089 Total recorded investment in impaired loans ​ $ 793 ​ $ 36 ​ $ 5,277 ​ $ 1,587 ​ $ — ​ $ 7,693 Specific allowance on impaired loans ​ $ 681 ​ $ — ​ $ 224 ​ $ 25 ​ $ — ​ $ 930 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 ​ ​ ​ ​ ​ ​ Average recorded investment in impaired loans ​ $ 3,237 ​ $ 812 ​ $ 5,493 ​ $ 898 ​ $ — ​ $ 10,440 Interest recognized ​ 1 ​ — ​ 6 ​ 8 ​ — ​ 15 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2021 ​ ​ ​ ​ ​ ​ Average recorded investment in impaired loans ​ 915 ​ 36 ​ 6,073 ​ 2,628 ​ — ​ 9,652 Interest recognized ​ 1 ​ — ​ 58 ​ 4 ​ — ​ 63 ​ Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan agreement are considered impaired. Impaired loans on accrual are comprised solely of TDR loans performing under modified loan agreements, whose principal and interest is determined to be collectible. Nonaccrual loans are loans where principal and interest have been determined to not be fully collectible. In situations where, for economic or legal reasons related to a borrower’s financial difficulties, the Company grants a concession to the borrower that it would not otherwise consider, the related loan is classified as a TDR loan. TDR loans are generally placed on nonaccrual status at the time of restructuring and included in impaired loans. These loans are returned to accrual status after the borrower demonstrates performance with the modified terms for a sustained period of time (generally six months) and has the capacity to continue to perform in accordance with the modified terms of the restructured debt. For the three months ended March 31, 2022 and 2021, the Company recorded no charge-offs related to TDR loans. During the three months ended March 31, 2022 and 2021, there were no TDR loans for which there was a payment default within the first 12 months of the modification. As of March 31, 2022 and December 31, 2021, TDR loans had a related allowance of $878,000 and $31,000, respectively. As of March 31, 2022 and December 31, 2021, $794,000 and $805,000, respectively, of TDR loans were performing in accordance with their modified terms. All TDR loans are also included in the loans individually evaluated for impairment as part of the calculation of the allowance for loan losses. There were no commitments to lend additional amounts to borrowers with outstanding loans that are classified as TDR loans at March 31, 2022. ​ A summary of TDR loans by type of concession and type of loan, as of the periods indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of Rate Term Rate & term ​ ​ ​ loans ​ modification ​ modification ​ modification ​ Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial 3 ​ $ — ​ $ 4,881 ​ $ — ​ $ 4,881 Construction and land — ​ — ​ — ​ — ​ — Commercial real estate 4 ​ — ​ 2,191 ​ — ​ 2,191 Residential 1 ​ — ​ ​ 128 ​ — ​ 128 Consumer — ​ — ​ — ​ — ​ — Total 8 ​ $ — ​ $ 7,200 ​ $ — ​ $ 7,200 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of Rate Term Rate & term ​ ​ ​ loans ​ modification ​ modification ​ modification ​ Total March 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial 2 ​ $ — ​ $ 29 ​ $ — ​ $ 29 Construction and land — ​ — ​ — ​ — ​ — Commercial real estate 3 ​ — ​ 1,422 ​ — ​ 1,422 Residential 1 ​ — ​ 150 ​ — ​ 150 Consumer — ​ — ​ — ​ — ​ — Total 6 ​ $ — ​ $ 1,601 ​ $ — ​ $ 1,601 ​ There was one loan modified as a TDR during the three months ended March 31, 2022. There were two loans modified as TDRs during the three months ended March 31, 2021. ​ Risk Rating System The Company evaluates and assigns a risk grade to each loan based on certain criteria to assess the credit quality of each loan. The assignment of a risk rating is done for each individual loan. Loans are graded from inception and on a continuing basis until the debt is repaid. Any adverse or beneficial trends will trigger a review of the loan risk rating. Each loan is assigned a risk grade based on its characteristics. Loans with low to average credit risk are assigned a lower risk grade than those with higher credit risk as determined by the individual loan characteristics. The Company’s Pass loans includes loans with acceptable business or individual credit risk where the borrower’s operations, cash flow or financial condition provides evidence of low to average levels of risk. Loans that are assigned higher risk grades are loans that exhibit the following characteristics: Special Mention loans have potential weaknesses that deserve close attention. If left uncorrected, these potential weaknesses may result in a deterioration of the repayment prospects for the loan or in the Company’s credit position at some future date. Special Mention loans are not adversely classified and do not expose the Company to sufficient risk to warrant adverse classification. A Special Mention rating is a temporary rating, pending the occurrence of an event that would cause the risk rating either to improve or to be downgraded. Loans in this category would be characterized by any of the following situations: ● Credit that is currently protected but is potentially a weak asset; ● Credit that is difficult to manage because of an inadequate loan agreement, the condition of and/or control over collateral, failure to obtain proper documentation, or any other deviation from product lending practices; and ● Adverse financial trends. Substandard loans are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged. Loans classified substandard must have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. The potential loss does not have to be recognizable in an individual credit for that credit to be risk rated Substandard. A loan can be fully and adequately secured and still be considered Substandard. Some characteristics of Substandard loans are: ● Inability to service debt from ordinary and recurring cash flow; ● Chronic delinquency; ● Reliance upon alternative sources of repayment; ● Term loans that are granted on liberal terms because the borrower cannot service normal payments for that type of debt; ● Repayment dependent upon the liquidation of collateral; ● Inability to perform as agreed, but adequately protected by collateral; ● Necessity to renegotiate payments to a non-standard level to ensure performance; and ● The borrower is bankrupt, or for any other reason, future repayment is dependent on court action. Doubtful loans have all the weaknesses inherent in loans classified as Substandard with the added characteristic that the weaknesses make collection or liquidation in full, based on currently existing facts, conditions, and value, highly questionable and improbable. Doubtful loans have a high probability of loss, yet certain important and reasonably specific pending factors may work toward the strengthening of the credit. Losses are recognized as charges to the allowance when the loan or portion of the loan is considered uncollectible or at the time of foreclosure. Recoveries on loans previously charged off are credited to the allowance for loan losses. The following tables present the internally assigned risk grade by class of loans at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Special ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ Mention ​ Substandard ​ Doubtful ​ Total March 31, 2022 ​ ​ ​ ​ ​ Commercial and industrial ​ $ 300,516 ​ $ 3,740 ​ $ 9,300 ​ $ — ​ $ 313,556 Construction and land ​ 17,830 ​ 2,988 ​ 36 ​ — ​ 20,854 Commercial real estate ​ 1,505,699 ​ 53,433 ​ 5,173 ​ — ​ 1,564,305 Residential ​ 98,742 ​ 1,527 ​ 1,810 ​ — ​ 102,079 Consumer ​ 3,653 ​ — ​ 22 ​ — ​ 3,675 Total ​ $ 1,926,440 ​ $ 61,688 ​ $ 16,341 ​ $ — ​ $ 2,004,469 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Special ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ Mention ​ Substandard ​ Doubtful ​ Total December 31, 2021 ​ ​ ​ ​ ​ Commercial and industrial ​ $ 216,611 ​ $ 9,178 ​ $ 4,388 ​ $ — ​ $ 230,177 Construction and land ​ 13,264 ​ 71 ​ 36 ​ — ​ 13,371 Commercial real estate ​ 1,264,269 ​ 28,438 ​ 6,977 ​ — ​ 1,299,684 Residential ​ 115,534 ​ 1,250 ​ 1,639 ​ — ​ 118,423 Consumer ​ 5,116 ​ — ​ 22 ​ — ​ 5,138 Total ​ $ 1,614,794 ​ $ 38,937 ​ $ 13,062 ​ $ — ​ $ 1,666,793 ​ The following tables provide an aging of the Company’s loans receivable as of the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Recorded ​ ​ ​ ​ ​ 90 Days ​ ​ ​ ​ ​ ​ ​ ​ investment > ​ ​ 30–59 Days ​ 60–89 Days ​ or more ​ Total ​ ​ ​ ​ ​ ​ ​ Total loans ​ 90 days and ​ ​ past due ​ past due ​ past due ​ past due ​ Current ​ PCI loans ​ receivable ​ accruing March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial ​ $ 5,828 ​ $ 236 ​ $ 653 ​ $ 6,717 ​ $ 302,380 ​ $ 4,459 ​ $ 313,556 ​ $ — Construction and land ​ 337 ​ — ​ 36 ​ 373 ​ 19,034 ​ 1,447 ​ 20,854 ​ — Commercial real estate ​ 109 ​ 697 ​ 3,119 ​ 3,925 ​ 1,536,959 ​ 23,421 ​ 1,564,305 ​ — Residential ​ 729 ​ 321 ​ ​ 1,002 ​ 2,052 ​ 98,457 ​ 1,570 ​ 102,079 ​ 117 Consumer ​ — ​ 221 ​ — ​ 221 ​ 3,454 ​ — ​ 3,675 ​ — Total ​ $ 7,003 ​ $ 1,475 ​ $ 4,810 ​ $ 13,288 ​ $ 1,960,284 ​ $ 30,897 ​ $ 2,004,469 ​ $ 117 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Recorded ​ ​ ​ ​ ​ 90 Days ​ ​ ​ ​ ​ ​ ​ ​ investment > ​ ​ 30–59 Days ​ 60–89 Days ​ or more ​ Total ​ ​ ​ ​ ​ ​ ​ Total loans ​ 90 days and ​ ​ past due ​ past due ​ past due ​ past due ​ Current ​ PCI loans ​ receivable ​ accruing December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial ​ $ 275 ​ $ 10 ​ $ 606 ​ $ 891 ​ $ 228,980 ​ $ 306 ​ $ 230,177 ​ $ — Construction and land ​ — ​ 338 ​ 36 ​ 374 ​ 12,997 ​ — ​ 13,371 ​ — Commercial real estate ​ 196 ​ 410 ​ 2,621 ​ 3,227 ​ 1,286,311 ​ 10,146 ​ 1,299,684 ​ — Residential ​ 1,442 ​ 21 ​ 1,031 ​ 2,494 ​ 114,162 ​ 1,767 ​ 118,423 ​ — Consumer ​ 3 ​ — ​ — ​ 3 ​ 5,135 ​ — ​ 5,138 ​ — Total ​ $ 1,916 ​ $ 779 ​ $ 4,294 ​ $ 6,989 ​ $ 1,647,585 ​ $ 12,219 ​ $ 1,666,793 ​ $ — ​ The balance of nonaccrual loans guaranteed by a government agency, which reduces the Company’s credit exposure, was $822,000 at March 31, 2022 compared to $841,000 at December 31, 2021. At March 31, 2022 and December 31, 2021, nonaccrual loans included $5.6 million and $6.9 million, respectively, of loans 30-89 days past due and $2.2 million and $2.5 million of loans less than 30 days past due, respectively. At March 31, 2022, nonaccrual loans 30-89 days past due of $5.6 million was primarily comprised of one $4.9 million commercial and industrial loan restructured as a TDR during the three months ended March 31, 2022 and seven smaller loans, and the $2.2 million of loans less than 30 days past due are comprised of 11 loans. All of these loans were placed on nonaccrual due to concerns over the financial condition of the borrowers. There was one loan totaling $117,000 that was 90 days or more past due and still accruing at March 31, 2022, compared to no loans at December 31, 2021. Interest foregone on nonaccrual loans was approximately $84,600 for the three months ended March 31, 2022 compared to $88,300 for the three months ended March 31, 2021. ​ Purchased Credit Impaired Loans In connection with the Company's acquisitions, the contractual amount and timing of undiscounted principal and interest payments and the estimated amount and timing of undiscounted expected principal and interest payments were used to estimate the fair value of PCI loans at the acquisition date. The difference between these two amounts represented the nonaccretable difference. On the acquisition date, the amount by which the undiscounted expected cash flows exceed the estimated fair value of the acquired loans is the “accretable yield”. The accretable yield is then measured at each financial reporting date and represented the difference between the remaining undiscounted expected cash flows and the current carrying value of the loans. For PCI loans the accretable yield is accreted into interest income over the life of the estimated remaining cash flows. At each financial reporting date, the carrying value of each PCI loan is compared to an updated estimate of expected principal payment or recovery on each loan. To the extent that the loan carrying amount exceeds the updated expected principal payment or recovery, a provision of loan loss would be recorded as a charge to income and an allowance for loan loss established. The unpaid principal balance and carrying value of the Company’s PCI loans at the dates indicated are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 ​ December 31, 2021 ​ Unpaid ​ ​ Unpaid ​ ​ ​ ​ principal ​ Carrying ​ principal ​ Carrying ​ ​ balance ​ value ​ balance ​ value Commercial and industrial ​ $ 5,587 ​ $ 4,459 ​ $ 546 ​ $ 306 Construction and land ​ 1,667 ​ 1,447 ​ — ​ — Commercial real estate ​ 25,751 ​ ​ 23,421 ​ 11,519 ​ 10,146 Residential ​ 1,943 ​ 1,570 ​ 2,202 ​ 1,767 Total ​ $ 34,948 ​ $ 30,897 ​ $ 14,267 ​ $ 12,219 ​ The following table reflects the changes in the accretable yield of PCI loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ ​ 2022 ​ 2021 ​ Balance at beginning of period ​ $ 508 ​ $ 383 ​ Additions ​ 1,277 ​ — ​ Removals ​ (48) ​ (65) ​ Accretion ​ (50) ​ (230) ​ Balance at end of period ​ $ 1,687 ​ $ 88 ​ ​

ALLOWANCE FOR LOAN LOSSES

ALLOWANCE FOR LOAN LOSSES	3 Months Ended
	Mar. 31, 2022
Allowance for Loan Losses [Abstract]
ALLOWANCE FOR LOAN LOSSES	NOTE 7 – ALLOWANCE FOR LOAN LOSSES The following tables summarize the Company’s allowance for loan losses and loan balances individually and collectively evaluated for impairment by type of loan as of or for the three months ended March 31, 2022 and 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial ​ Construction ​ Commercial ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ and industrial and land real estate Residential Consumer Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses ​ ​ ​ ​ ​ ​ Beginning balance ​ $ 3,261 ​ $ 175 ​ $ 12,709 ​ $ 1,536 ​ $ 19 ​ $ 17,700 Charge-offs ​ — ​ — ​ (1) ​ (6) ​ (3) ​ (10) Recoveries ​ 3 ​ — ​ — ​ — ​ — ​ 3 Provision for (reversal of) loan losses ​ 235 ​ ​ (37) ​ ​ 264 ​ ​ (457) ​ ​ 2 ​ 7 Ending balance ​ $ 3,499 ​ $ 138 ​ $ 12,972 ​ $ 1,073 ​ $ 18 ​ $ 17,700 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses by methodology: ​ ​ ​ ​ ​ ​ Loans individually evaluated for impairment ​ $ 1,277 ​ $ — ​ $ 259 ​ $ 128 ​ $ — ​ $ 1,664 Loans collectively evaluated for impairment ​ 2,222 ​ 138 ​ 12,713 ​ 945 ​ 18 ​ 16,036 PCI loans ​ — ​ — ​ — ​ — ​ — ​ — ​ ​ ​ ​ ​ ​ ​ Loans receivable by methodology: ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 5,723 ​ $ 36 ​ $ 5,710 ​ $ 1,759 ​ $ — ​ $ 13,228 Collectively evaluated for impairment ​ 303,374 ​ 19,371 ​ 1,535,174 ​ 98,750 ​ 3,675 ​ 1,960,344 PCI loans ​ 4,459 ​ 1,447 ​ 23,421 ​ 1,570 ​ — ​ 30,897 Total loans ​ $ 313,556 ​ $ 20,854 ​ $ 1,564,305 ​ $ 102,079 ​ $ 3,675 ​ $ 2,004,469 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial ​ Construction ​ Commercial ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ and industrial and land real estate Residential Consumer Total March 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses ​ ​ ​ ​ ​ ​ Beginning balance ​ $ 4,042 ​ $ 378 ​ $ 11,211 ​ $ 1,856 ​ $ 13 ​ $ 17,500 Charge-offs ​ (2) ​ — ​ — ​ — ​ — ​ (2) Recoveries ​ 2 ​ — ​ — ​ — ​ — ​ 2 Provision for (reversal of) loan losses ​ (223) ​ ​ (113) ​ ​ 36 ​ ​ 291 ​ ​ 9 ​ — Ending balance ​ $ 3,819 ​ $ 265 ​ $ 11,247 ​ $ 2,147 ​ $ 22 ​ $ 17,500 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses by methodology: ​ ​ ​ ​ ​ ​ Loans individually evaluated for impairment ​ $ 490 ​ $ — ​ $ 116 ​ $ 20 ​ $ — ​ $ 626 Loans collectively evaluated for impairment ​ 3,218 ​ 265 ​ 11,131 ​ 2,127 ​ 22 ​ 16,763 PCI loans ​ 111 ​ — ​ — ​ — ​ — ​ 111 ​ ​ ​ ​ ​ ​ ​ ​ Loans receivable by methodology: ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 978 ​ $ 36 ​ $ 6,079 ​ $ 3,524 ​ $ — ​ $ 10,617 Collectively evaluated for impairment ​ 322,330 ​ 14,539 ​ 1,078,547 ​ 141,909 ​ 6,832 ​ 1,564,157 PCI loans ​ 638 ​ 48 ​ 11,135 ​ 2,252 ​ — ​ 14,073 Total loans ​ $ 323,946 ​ $ 14,623 ​ $ 1,095,761 ​ $ 147,685 ​ $ 6,832 ​ $ 1,588,847 ​

PREMISES AND EQUIPMENT

PREMISES AND EQUIPMENT	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
PREMISES AND EQUIPMENT	NOTE 8 – PREMISES AND EQUIPMENT Premises and equipment consisted of the following at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Premises owned ​ $ 11,115 ​ $ 11,015 Leasehold improvements ​ 2,619 ​ 2,608 Furniture, fixtures and equipment ​ 6,462 ​ 6,201 Less accumulated depreciation and amortization ​ (5,939) ​ (5,454) Total premises and equipment, net ​ $ 14,257 ​ $ 14,370 ​ Depreciation and amortization included in occupancy and equipment expense totaled $507,000 and $502,000 for the three months ended March 31, 2022 and 2021, respectively.

LEASES

LEASES	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
LEASES	NOTE 9 – LEASES The Company leases 19 branches under noncancelable operating leases. These leases expire on various dates through 2030. The Company’s leases often have an option to renew one or more times, at the Company’s discretion, following the expiration of the initial term. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. ​ The Company uses the rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception, on a collateralized basis, over a similar term. ​ The below maturity schedule represents the undiscounted lease payments for the five-year period and thereafter as of March 31, 2022: ​ ​ ​ ​ ​ For remainder of 2022 ​ $ 3,832 2023 ​ 3,466 2024 ​ 2,952 2025 ​ 2,039 2026 ​ ​ 1,296 Thereafter ​ 2,563 Total undiscounted cash flows ​ ​ 16,148 Less: interest ​ ​ (1,971) Present value of lease payments ​ $ 14,177 ​ ​ The following table presents the weighted average lease term and discount rate at the date indicated: ​ ​ ​ ​ ​ ​ March 31, 2022 Weighted-average remaining lease term 5.1 years Weighted-average discount rate 2.41 % ​ ​

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 10 – GOODWILL AND INTANGIBLE ASSETS Goodwill is determined as the excess of the fair value of the consideration transferred, plus the fair value of any noncontrolling interests in the acquiree, over the fair value of the net assets acquired and the liabilities assumed as of the acquisition date. Goodwill and other intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Intangible assets with definite useful lives are amortized over their estimated useful lives to their estimated residual values. Core deposit intangible represents the estimated future benefit of deposits related to an acquisition and is booked separately from the related deposits and amortized over an estimated useful live of seven Goodwill The Company’s policy is to assess goodwill for impairment at the reporting unit level on an annual basis or between annual assessments if a triggering event occurs or circumstances change that would more likely than not Changes in the Company's goodwill at March 31, 2022 and December 31, 2021 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Balance at beginning of period ​ $ 38,838 ​ $ 38,838 Acquired goodwill ​ — ​ — Impairment ​ — ​ — Balance at end of period ​ $ 38,838 ​ $ 38,838 ​ ​ Core Deposit Intangible Changes in the Company’s core deposit intangible at March 31, 2022 and December 31, 2021 were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Balance at beginning of period ​ $ 6,489 ​ $ 8,302 Additions ​ 756 ​ — Less amortization ​ (495) ​ (1,813) Balance at end of period ​ $ 6,750 ​ $ 6,489 ​ ​ Estimated annual amortization expense at March 31, 2022 is as follows: ​ ​ ​ ​ ​ For remainder of 2022 ​ $ 1,549 2023 ​ 1,286 2024 ​ 1,222 2025 ​ 948 2026 ​ ​ 455 Thereafter ​ 1,290 Total ​ $ 6,750 ​

INTEREST RECEIVABLE AND OTHER A

INTEREST RECEIVABLE AND OTHER ASSETS	3 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
INTEREST RECEIVABLE AND OTHER ASSETS	NOTE 11 – INTEREST RECEIVABLE AND OTHER ASSETS The Company’s interest receivable and other assets at the dates indicated consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Tax assets, net ​ $ 11,391 ​ $ 10,573 Accrued interest receivable ​ 8,262 ​ 5,929 Investment in Small Business Investment Company ("SBIC") fund ​ 4,929 ​ 4,731 Investment in Community Reinvestment Act fund ​ ​ 2,000 ​ ​ — Prepaid assets ​ 1,076 ​ 1,598 Servicing assets ​ 2,365 ​ 1,947 Investment in Low Income Housing Tax Credit ("LIHTC") partnerships, net ​ 2,981 ​ 3,129 Investment in statutory trusts ​ 485 ​ 484 Other assets ​ 5,644 ​ 1,469 Total ​ $ 39,133 ​ $ 29,860 ​

DEPOSITS

DEPOSITS	3 Months Ended
	Mar. 31, 2022
Deposits [Abstract]
DEPOSITS	NOTE 12 – DEPOSITS The Company’s deposits consisted of the following at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Demand deposits ​ $ 783,110 ​ $ 710,137 NOW accounts and savings ​ 476,077 ​ 484,847 Money market ​ 760,359 ​ 568,094 Time deposits ​ 310,849 ​ 222,161 Total ​ $ 2,330,395 ​ $ 1,985,239 ​

BORROWINGS

BORROWINGS	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
BORROWINGS	NOTE 13 - BORROWINGS Other borrowings The Company has Federal Funds lines with four corresponding banks. Cumulative available commitments totaled $65.0 million at both March 31, 2022 and December 31, 2021. There were no amounts outstanding under these facilities at both March 31, 2022 and December 31, 2021. Junior subordinated deferrable interest debentures – In connection with its previous acquisitions, the Company acquired junior subordinated deferrable interest debentures, totaling $8.4 net of mark-to-market adjustments March 31, 2022 with a weighted average interest rate of 3.44% , compared to $8.4 million with a weighted average rate of 2.79% at December 31, 2021 . The junior subordinated deferrable interest debentures have a stated maturity term of 30 years . Subordinated debt the aggregate principal amount of the Notes. The offering of the Notes closed on August 10, 2020. The Notes initially bears a fixed interest rate of 5.25% per year. Commencing on September 15, 2025, the interest rate on the Notes resets quarterly to the three-month Secured Overnight Financing rate plus a spread of 521 basis points (5.21%), payable quarterly in arrears. Interest on the Notes is payable semi-annually on March 15 and September 15 of each year through September 15, 2025 and quarterly thereafter on March 15, June 15, September 15 and December 15 of each year through the maturity date or early redemption date. The Company, at its option, may redeem the Notes, in whole or in part, on any interest payment date on or after September 15, 2025, without a premium. At March 31, 2022 and December 31, 2021, the Company had outstanding Notes, net of cost to issue, totaling $63.6 million and $63.5 million, respectively.

INTEREST PAYABLE AND OTHER LIAB

INTEREST PAYABLE AND OTHER LIABILITIES	3 Months Ended
	Mar. 31, 2022
Other Liabilities Disclosure [Abstract]
INTEREST PAYABLE AND OTHER LIABILITIES	NOTE 14 – INTEREST PAYABLE AND OTHER LIABILITIES The Company’s interest payable and other liabilities at the dates indicated consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Accrued expenses ​ $ 5,634 ​ $ 7,339 Accounts payable ​ 412 ​ 506 Reserve for unfunded commitments ​ 315 ​ 315 Accrued interest payable ​ 344 ​ 1,180 Other liabilities ​ 3,557 ​ 4,516 Total ​ $ 10,262 ​ $ 13,856 ​

OTHER EXPENSES

OTHER EXPENSES	3 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
OTHER EXPENSES	NOTE 15 – OTHER EXPENSES The Company’s other expenses for the periods indicated consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2022 ​ 2021 ​ Professional fees ​ $ 1,306 ​ $ 434 ​ Core deposit premium amortization ​ 495 ​ 454 ​ Marketing and promotions ​ 296 ​ 64 ​ Stationery and supplies ​ 92 ​ 107 ​ Insurance (including FDIC premiums) ​ 231 ​ 210 ​ Communication and postage ​ 224 ​ 214 ​ Loan default related expense ​ 39 ​ 14 ​ Director fees ​ 84 ​ 76 ​ Bank service charges ​ 66 ​ 56 ​ Courier expense ​ 175 ​ 176 ​ Other ​ 304 ​ 96 ​ Total ​ $ 3,312 ​ $ 1,901 ​ ​ ​

EQUITY INCENTIVE PLANS

EQUITY INCENTIVE PLANS	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
EQUITY INCENTIVE PLANS	NOTE 16 – EQUITY INCENTIVE PLANS Equity Incentive Plans 2017 Omnibus Equity Incentive Plan The shareholders approved the Omnibus Equity Incentive Plan (“2017 Plan”) in November 2017. The 2017 Plan provides for the awarding by the Company’s Board of Directors of equity incentive awards to employees and non-employee directors. An equity incentive award may be an option, stock appreciation rights, restricted stock units, stock award, other stock-based award or performance award granted under the 2017 Plan. Factors considered by the Board in awarding equity incentives to officers and employees include the performance of the Company, the employee’s or officer’s job performance, the importance of his or her position, and his or her contribution to the organization’s goals for the award period. Generally, awards are restricted and have a vesting period of no longer than ten years. Subject to adjustment as provided in the 2017 Plan, the maximum number of shares of common stock that may be delivered pursuant to awards granted under the 2017 Plan is 450,000 . The 2017 Plan provides for an annual restricted stock grant limits to officers, employees and directors. The annual stock grant limit per person for officers and employees is the lessor of 50,000 shares or a value of $2.0 million, and per person for directors, the maximum is 25,000 shares. All unvested restricted shares outstanding vest in the event of a change in control of the Company. Awarded shares of restricted stock vest over (i) a one-year period following the date of grant, in the case of the non-employee directors, and (ii) a three-year or five-year period following the date of grant, with the initial vesting occurring on the one-year anniversary of the date of grant, in the case of the executive officers. As of March 31, 2022, a total of 95,381 shares were available for future issuance under the 2017 Plan. 2014 Omnibus Equity Incentive Plan In 2014, the shareholders approved the Omnibus Equity Incentive Plan (the “2014 Plan”). A total of 148,962 equity incentive awards were granted under the 2014 Plan. The awards are shares of restricted stock and have a vesting period of one The Company recognizes compensation expense for the restricted stock awards based on the fair value of the shares at the award date. For the three months ended March 31, 2022 and 2021, total compensation expense for these plans was $324,000 and $413,000, respectively. As of March 31, 2022, there was $1.5 million of total unrecognized compensation cost related to non-vested shares granted as restricted stock awards. The cost is expected to be recognized over the remaining weighted-average vesting period of approximately three years. The following table provides the restricted stock grant activity for the periods indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 ​ 2021 ​ ​ ​ Weighted-average ​ Weighted-average ​ ​ ​ ​ grant date ​ ​ ​ grant date ​ ​ Shares ​ fair value ​ Shares ​ fair value Non-vested at January 1, 139,275 ​ $ 16.29 ​ 204,515 ​ $ 17.71 ​ Granted 22,473 ​ 18.79 ​ 24,187 ​ 15.17 ​ Vested (15,560) ​ 18.34 ​ (14,164) ​ 18.50 ​ Forfeited ​ (532) ​ ​ 18.79 ​ — ​ ​ — ​ Non-Vested, at March 31, 145,656 ​ $ 16.45 ​ 214,538 ​ $ 16.06 ​ ​

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENT	NOTE 17 – FAIR VALUE MEASUREMENT ASC Topic 820, “Fair Value Measurement,” defines fair value, establishes a framework for measuring fair value including a three-level valuation hierarchy, and expands disclosures about fair value measurements. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date reflecting assumptions that a market participant would use when pricing an asset or liability. The hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows: Level 1 Level 2 Level 3 We use fair value to measure certain assets and liabilities on a recurring basis, primarily securities available-for-sale. For assets measured at the lower of cost or fair value, the fair value measurement criteria may or may not be met during a reporting period and such measurements are therefore considered “nonrecurring” for purposes of disclosing our fair value measurements. Fair value is used on a nonrecurring basis to adjust carrying values for impaired loans and other real estate owned and also to record impairment on certain assets, such as goodwill, core deposit intangible, and other long-lived assets. In certain cases, the inputs used to measure fair value may fall into different levels of the hierarchy. In such cases, the lowest level of inputs that is significant to the measurement is used to determine the hierarchy for the entire asset or liability. Transfers between levels of the fair value hierarchy are recognized on the actual date of the event or circumstances that caused the transfer, which generally coincides with our quarterly valuation process. There were no transfers between levels during 2022 or 2021. The following assets are measured at fair value on a recurring basis as of the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,508 ​ $ — ​ $ 1,508 ​ $ — Municipal securities ​ 22,531 ​ — ​ 22,531 ​ — Mortgage-backed securities ​ 35,294 ​ — ​ 35,294 ​ — Collateralized mortgage obligations ​ 29,421 ​ — ​ 29,421 ​ — SBA securities ​ 5,652 ​ — ​ 5,652 ​ — Corporate bonds ​ 73,569 ​ — ​ 73,569 ​ — Equity securities ​ ​ 16,698 ​ ​ 16,698 ​ ​ — ​ ​ — Total ​ $ 184,673 ​ $ 16,698 ​ $ 167,975 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,510 ​ $ — ​ $ 1,510 ​ $ — Municipal securities ​ 24,123 ​ — ​ 24,123 ​ — Mortgage-backed securities ​ 35,096 ​ — ​ 35,096 ​ — Collateralized mortgage obligations ​ 27,506 ​ — ​ 27,506 ​ — SBA securities ​ 6,088 ​ — ​ 6,088 ​ — Corporate bonds ​ 61,335 ​ — ​ 61,335 ​ — Equity securities ​ ​ 18,777 ​ ​ 18,777 ​ ​ — ​ ​ — Total ​ $ 174,435 ​ $ 18,777 ​ $ 155,658 ​ $ — ​ The following assets are measured at fair value on a nonrecurring basis as of the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ Performing impaired loans ​ $ 794 ​ $ — ​ $ — ​ $ 794 Nonperforming impaired loans ​ 12,434 ​ — ​ — ​ 12,434 OREO ​ 21 ​ — ​ — ​ 21 Total ​ $ 13,249 ​ $ — ​ $ — ​ $ 13,249 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ Performing impaired loans ​ $ 805 ​ $ — ​ $ — ​ $ 805 Nonperforming impaired loans ​ 6,888 ​ — ​ — ​ 6,888 OREO ​ 21 ​ — ​ — ​ 21 Total ​ $ 7,714 ​ $ — ​ $ — ​ $ 7,714 ​ ​ The Company does not record loans at fair value on a recurring basis. However, from time to time, a loan may be considered impaired and an allowance for loan losses is established. Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan agreement are considered impaired. The fair value of impaired loans is estimated using one of several methods, including collateral value, market value of similar debt, enterprise and liquidation value and discounted cash flows. Those impaired loans not requiring an allowance represent loans for which the fair value of the expected repayments or collateral exceed the recorded investments in such loans. When the fair value of the collateral is based on an observable market price or a current appraised value which uses substantially observable data, the Company records the impaired loan as nonrecurring Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value or the appraised value contains a significant assumption and there is no observable market price, the Company records the impaired loan as nonrecurring Level 3. The Company records OREO at fair value on a nonrecurring basis based on the collateral value of the property. When the fair value of the collateral is based on an observable market price or a current appraised value which uses substantially observable data, the Company records the OREO as nonrecurring Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value or the appraised value contains a significant assumption, and there is no observable market price, the Company records the impaired loan as nonrecurring Level 3. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Management also incorporates assumptions regarding market trends or other relevant factors and selling and commission costs ranging from 5% to 7%. Such adjustments and assumptions are typically significant and result in a Level 3 classification of the inputs for determining fair value.

FAIR VALUE OF FINANCIAL INSTRUM

FAIR VALUE OF FINANCIAL INSTRUMENTS	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	NOTE 18 – FAIR VALUE OF FINANCIAL INSTRUMENTS The following methods and assumptions were used to estimate the fair value disclosure for financial instruments: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Fair ​ Fair value measurements ​ amount value Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 427,199 ​ $ 427,199 ​ $ 427,199 ​ $ — ​ $ — Interest bearing deposits in banks ​ 3,336 ​ 3,336 ​ 3,336 ​ — ​ — Investment securities available-for-sale ​ 167,975 ​ 167,975 ​ — ​ 167,975 ​ — Equity securities ​ ​ 16,698 ​ ​ 16,698 ​ ​ 16,698 ​ ​ — ​ ​ — Investment in FHLB and FRB Stock ​ 19,226 ​ 19,226 ​ 19,226 ​ — ​ — Loans held for sale ​ 970 ​ 970 ​ — ​ 970 ​ — Loans, net ​ 1,986,228 ​ 1,991,792 ​ — ​ — ​ 1,991,792 Accrued interest receivable ​ 8,262 ​ 8,262 ​ — ​ 8,262 ​ — Financial liabilities: ​ ​ ​ ​ ​ Deposits ​ 2,330,395 ​ 2,332,443 ​ — ​ 2,332,443 ​ — Junior subordinated deferrable interest debentures, net ​ ​ 8,423 ​ ​ 8,640 ​ ​ — ​ ​ — ​ ​ 8,640 Subordinated debt, net ​ ​ 63,584 ​ 63,584 ​ — ​ ​ 63,584 ​ ​ — Accrued interest payable ​ 344 ​ 344 ​ — ​ 344 ​ — Off-balance sheet liabilities: ​ ​ ​ ​ ​ ​ Undisbursed loan commitments, lines of credit, standby letters of credit ​ 89,054 ​ 88,739 ​ — ​ — ​ 88,739 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Fair ​ Fair value measurements ​ amount value Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 379,687 ​ $ 379,687 ​ $ 379,687 ​ $ — ​ $ — Interest bearing deposits in banks ​ 3,585 ​ 3,585 ​ 3,585 ​ — ​ — Investment securities available-for-sale ​ 155,658 ​ 155,658 ​ — ​ 155,658 ​ — Equity securities ​ ​ 18,777 ​ ​ 18,777 ​ ​ 18,777 ​ ​ ​ ​ ​ ​ Investment in FHLB and FRB Stock ​ 16,035 ​ 16,035 ​ 16,035 ​ — ​ — Loans held for sale ​ 6,470 ​ 6,470 ​ — ​ 6,470 ​ — Loans, net ​ 1,647,190 ​ 1,659,811 ​ — ​ — ​ 1,659,811 Accrued interest receivable ​ 5,929 ​ 5,929 ​ — ​ 5,929 ​ — Financial liabilities: ​ ​ ​ ​ ​ Deposits ​ 1,985,239 ​ 1,986,651 ​ — ​ 1,986,651 ​ — Junior subordinated deferrable interest debentures, net ​ 8,403 ​ 8,612 ​ — ​ — ​ 8,612 Subordinated debt, net ​ 63,542 ​ 63,542 ​ — ​ 63,542 ​ — Accrued interest payable ​ 1,180 ​ 1,180 ​ — ​ 1,180 ​ — Off-balance sheet liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Undisbursed loan commitments, lines of credit, standby letters of credit ​ 104,139 ​ 103,824 ​ — ​ — ​ 103,824 ​

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 19 – COMMITMENTS AND CONTINGENCIES Lending and Letter of Credit Commitments We operate in a highly regulated environment. From time to time we are a party to various claims and litigation matters incidental to the conduct of our business. We are not presently party to any legal proceedings where we believe the resolution would have a material adverse effect on our business, financial condition, or results of operations. Nevertheless, given the nature, scope and complexity of the extensive legal and regulatory landscape applicable to our business (including laws and regulations governing consumer protection, fair lending, fair labor, privacy, information security and anti-money laundering and anti-terrorism laws), we, like all banking organizations, are subject to heightened legal and regulatory compliance and litigation risk. In the normal course of business, the Company enters into various commitments to extend credit, which are not reflected in the financial statements. These commitments consist of the undisbursed balance on personal, commercial lines, including commercial real estate secured lines of credit, and of undisbursed funds on construction and development loans. The Company also issues standby letter of credit commitments, primarily for the third-party performance obligations of clients. The following table presents a summary of commitments described above as of the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Commitments to extend credit ​ $ 86,292 ​ $ 100,686 Standby letters of credit ​ 2,762 ​ 3,453 Total commitments ​ $ 89,054 ​ $ 104,139 ​ Commitments generally have fixed expiration dates or other termination clauses. The actual liquidity needs or the credit risk that the Company will experience will be lower than the contractual amount of commitments to extend credit because a significant portion of these commitments are expected to expire without being drawn upon. The commitments are generally variable rate and include unfunded home equity lines of credit, commercial real estate construction where disbursement is made over the course of construction, commercial revolving lines of credit, and unsecured personal lines of credit. The Company’s outstanding loan commitments are made using the same underwriting standards as comparable outstanding loans. The reserve associated with these commitments included in interest payable and other liabilities on the consolidated balance sheets was Commercial Real Estate Concentrations At March 31, 2022 and December 31, 2021, in management’s judgment, a concentration of loans existed in commercial real estate related loans. The Company’s commercial real estate loans are secured by owner-occupied and non-owner occupied commercial real estate and multifamily properties. Although management believes that loans within these concentrations have no more than the normal risk of collectability, a decline in the performance of the economy in general or a decline in real estate value in the Company’s primary market areas in particular, could have an adverse impact on collectability Other Assets The Company has commitments to fund investments in LIHTC partnerships and an SBIC fund. At March 31, 2022, the remaining commitments to the LIHTC partnerships and the SBIC fund were approximately $3.2 million and $122,000, respectively. At December 31, 2021, the remaining commitments to the LIHTC partnerships and the SBIC fund were $2.3 million and $122,000 , respectively. Deposits At March 31, 2022, approximately $265.9 million, or 11.4%, of the Company's deposits were derived from its top ten depositors. At December 31, 2021, approximately $198.6 million, or 10.0%, of the Company's deposits were derived from its top ten depositors. Local Agency Deposits and Other Advances In the normal course of business, the Company accepts deposits from local agencies. The Company is required to provide collateral for certain local agency deposits in the states of California, Colorado, New Mexico and Washington. At both March 31, 2022 and December 31, 2021, the FHLB issued letters of credit on behalf of the Company totaling $42.0 million as collateral for local agency deposits.

RESTATEMENT OF THE CONSOLIDAT_2

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Prior Period Adjustment [Abstract]
Schedule of effect of the restatement on financial statements	The tables below show the effects of the restatement on the Company’s condensed consolidated balance sheets, condensed consolidated statements of income, condensed consolidated statements of comprehensive loss, condensed consolidated statements of changes in shareholders’ equity, and condensed consolidated statement of cash flows as of and for the quarter ended March 31, 2022 (in thousands, except for per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 Consolidated Balance Sheet ​ (As Previously Reported) Adjustments (As Restated) ASSETS ​ ​ ​ Cash and due from banks ​ $ 35,532 $ — $ 35,532 Federal funds sold ​ 391,667 — 391,667 Cash and cash equivalents ​ ​ 427,199 ​ — ​ 427,199 Interest bearing deposits in banks ​ ​ 3,336 ​ — ​ 3,336 Investment securities available-for-sale ​ ​ 184,673 ​ (16,698) ​ 167,975 Equity securities ​ ​ — ​ 16,698 ​ 16,698 Federal Home Loan Bank ("FHLB") stock, at par ​ ​ 10,679 ​ — ​ 10,679 Federal Reserve Bank ("FRB") stock, at par ​ ​ 8,547 ​ — ​ 8,547 Loans held for sale ​ ​ 970 ​ — ​ 970 Loans, net of allowance for loan losses of $17,700 at March 31, 2022 and $17,700 December 31, 2021 ​ ​ 1,986,228 ​ — ​ 1,986,228 Premises and equipment, net ​ ​ 14,257 ​ — ​ 14,257 Other real estate owned ("OREO") ​ ​ 21 ​ — ​ 21 Core deposit intangible, net ​ ​ 6,750 ​ — ​ 6,750 Cash surrender value of bank owned life insurance ("BOLI") policies, net ​ ​ 21,736 ​ — ​ 21,736 Right-of-use assets ("ROU"), net ​ ​ 13,645 ​ — ​ 13,645 Goodwill ​ ​ 38,838 ​ — ​ 38,838 Interest receivable and other assets ​ ​ 39,133 ​ — ​ 39,133 Total assets ​ $ 2,756,012 $ — $ 2,756,012 LIABILITIES AND SHAREHOLDERS’ EQUITY ​ ​ ​ ​ Noninterest and interest bearing deposits ​ $ 2,330,395 $ — $ 2,330,395 Junior subordinated deferrable interest debentures, net ​ 8,423 — 8,423 Subordinated debt, net ​ ​ 63,584 ​ — ​ 63,584 Salary continuation plan ​ 4,517 — 4,517 Lease liabilities ​ 14,177 — 14,177 Interest payable and other liabilities ​ 10,262 — 10,262 Total liabilities ​ 2,431,358 — 2,431,358 Commitments and contingencies (Note 19) ​ Shareholders' equity ​ Preferred stock, no par value; 10,000,000 shares authorized; no shares issued and outstanding at both March 31, 2022 and December 31, 2021 ​ — — — Common stock, no par value; 100,000,000 shares authorized; 13,677,729 and 10,680,386 shares issued outstanding ​ 220,294 — 220,294 Additional paid in capital ​ 287 — 287 Accumulated other comprehensive loss, net of tax ​ (4,786) 1,259 (3,527) Retained earnings ​ 108,859 (1,259) 107,600 Total shareholders’ equity ​ 324,654 — 324,654 Total liabilities and shareholders’ equity ​ $ 2,756,012 $ — $ 2,756,012 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Income (As Previously Reported) ​ Adjustments ​ (As Restated) Interest income: ​ ​ ​ ​ ​ ​ ​ ​ ​ Loans, including fees ​ $ 22,927 ​ $ — ​ $ 22,927 Investment securities and interest bearing deposits in banks ​ 1,608 ​ — ​ 1,608 FHLB dividends ​ 149 ​ — ​ 149 FRB dividends ​ 121 ​ — ​ 121 Total interest and dividend income ​ 24,805 ​ — ​ 24,805 Interest expense: ​ ​ ​ Deposits ​ 1,470 ​ — ​ 1,470 Subordinated debt ​ ​ 896 ​ ​ — ​ ​ 896 Other borrowings ​ 86 ​ — ​ 86 Total interest expense ​ 2,452 ​ — ​ 2,452 Net interest income ​ 22,353 ​ — ​ 22,353 Provision for loan losses ​ 7 ​ — ​ 7 Net interest income after provision for loan losses ​ 22,346 ​ — ​ 22,346 Noninterest income: ​ ​ ​ Gain on sale of loans ​ 1,137 ​ — ​ 1,137 Loss on equity securities ​ ​ — ​ ​ (1,768) ​ ​ (1,768) Service charges and other fees ​ 630 ​ — ​ 630 Loan servicing and other loan fees ​ 574 ​ — ​ 574 Income on investment in Small Business Investment Company (“SBIC”) fund ​ 197 ​ — ​ 197 Bargain purchase gain ​ ​ 1,665 ​ ​ — ​ ​ 1,665 Other income and fees ​ 196 ​ — ​ 196 Total noninterest income ​ 4,399 ​ (1,768) ​ 2,631 Noninterest expense: ​ ​ ​ Salaries and employee benefits ​ 10,310 ​ — ​ 10,310 Occupancy and equipment ​ 2,426 ​ — ​ 2,426 Data processing ​ 2,273 ​ — ​ 2,273 Other expense ​ 3,312 ​ — ​ 3,312 Total noninterest expense ​ 18,321 ​ — ​ 18,321 Income before provision for income taxes ​ 8,424 ​ (1,768) ​ 6,656 Provision for income taxes ​ 1,936 ​ (509) ​ 1,427 Net income ​ $ 6,488 ​ $ (1,259) ​ $ 5,229 Earnings per common share: ​ ​ ​ Basic earnings per common share ​ $ 0.51 ​ $ (0.10) ​ $ 0.41 Weighted average shares outstanding ​ 12,646,981 ​ 12,646,981 ​ 12,646,981 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Comprehensive Loss ​ (As Previously Reported) ​ Adjustments ​ (As Restated) Net income ​ $ 6,488 ​ $ (1,259) ​ $ 5,229 Other comprehensive loss: ​ ​ ​ ​ ​ ​ Change in unrealized loss on available-for-sale securities ​ (9,761) ​ 1,768 ​ (7,993) Deferred tax benefit ​ 2,809 ​ (509) ​ 2,300 Other comprehensive loss, net of tax ​ (6,952) ​ 1,259 ​ (5,693) Total comprehensive loss ​ $ (464) ​ $ — ​ $ (464) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 Consolidated Statement of Cash Flow Changes (As Previously Reported) ​ Adjustments ​ (As Restated) Cash flows from operating activities: ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 6,488 ​ ​ (1,259) ​ ​ 5,229 Adjustments to reconcile net income to net cash provided by operating activities: ​ ​ ​ ​ ​ Decrease in deferred tax assets ​ 2,818 ​ ​ (509) ​ ​ 2,309 Loss on equity securities ​ ​ — ​ ​ 1,768 ​ ​ 1,768 Net cash provided by operating activities ​ 2,846 ​ ​ — ​ ​ 2,846 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash investing and financing activities: ​ ​ ​ Change in unrealized loss on available-for-sale securities, net of tax ​ $ (6,952) ​ $ 1,259 ​ $ (5,693)

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Schedule of fair value of the assets acquired and liabilities assumed	The following table summarizes the fair value of the assets acquired and liabilities assumed at the acquisition date: ​ ​ ​ ​ ​ ​ ​ PEB ​ ​ Acquisition ​ ​ ​ Date ​ ​ ​ February 1, 2022 ​ Fair value of assets: ​ Cash and due from banks ​ $ 5,350 ​ Total cash and cash equivalents ​ 5,350 ​ ​ ​ ​ ​ ​ Interest bearing deposits in banks ​ 13,348 ​ Investment securities available-for-sale ​ ​ 3 ​ FHLB stock, at par ​ 2,294 ​ FRB stock, at par ​ 942 ​ Loans, net ​ 412,851 ​ Premises and equipment, net ​ ​ 221 ​ Core deposit intangible ​ 756 ​ Deferred tax assets, net ​ 1,192 ​ Interest receivable and other assets ​ ​ 9,178 ​ Total assets acquired ​ 446,135 ​ Liabilities: ​ ​ Deposits ​ ​ Noninterest bearing ​ 60,006 ​ Interest bearing ​ 316,679 ​ Total Deposits ​ 376,685 ​ ​ ​ ​ ​ ​ Interest payable and other liabilities ​ ​ 3,370 ​ Total liabilities assumed ​ ​ 380,055 ​ ​ ​ ​ ​ ​ Stock consideration ​ 64,140 ​ Cash consideration ​ 275 ​ Bargain purchase gain ​ $ 1,665 ​ ​ The following table presents the net assets acquired and the estimated fair value adjustments, which resulted in bargain purchase gain at the acquisition date: ​ ​ ​ ​ ​ ​ ​ PEB ​ ​ Acquisition ​ ​ ​ Date ​ ​ ​ February 1, 2022 ​ Book value of net assets acquired ​ $ 61,469 ​ Fair value adjustments: ​ ​ Loans, net ​ 5,840 ​ Premises and equipment, net ​ ​ 26 ​ Core deposit intangible ​ 756 ​ Time deposits ​ ​ (869) ​ Reserve for unfunded commitments ​ 283 ​ Write-up right-of-use asset ​ 439 ​ Total purchase accounting adjustments ​ 6,475 ​ ​ ​ ​ ​ ​ Tax effect of purchase accounting adjustments at 27.9% ​ (1,864) ​ Fair value of assets acquired ​ 66,080 ​ Value of stock issued/cash paid for stock options ​ 64,415 ​ Bargain purchase gain ​ $ (1,665) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
Schedule of unaudited pro forma net interest income, net income and earnings per share	Unaudited pro forma net interest income, net income and earnings per share are presented below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended March 31, ​ ​ ​ ​ 2022 (As Restated) ​ ​ 2021 ​ Net interest income ​ $ 23,205 ​ $ 24,271 ​ Net income ​ 1,869 ​ 6,084 ​ Basic earnings per share ​ $ 0.14 ​ $ 0.42 ​ Diluted earnings per share ​ ​ 0.14 ​ ​ 0.42 ​
Schedule of acquisition expenses	​ ​ ​ ​ ​ Severance expense $ 556 Occupancy expense ​ 375 Data processing ​ 1,073 Professional fees ​ ​ 724 Other expenses ​ 347 Total ​ $ 3,075

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of amortized cost and estimated fair values of securities available-for-sale	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ ​ cost ​ gains ​ losses ​ fair value March 31, 2022 (As Restated) ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,509 ​ $ — ​ $ (1) ​ $ 1,508 ​ Municipal securities ​ 23,541 ​ 56 ​ (1,066) ​ 22,531 ​ Mortgage-backed securities ​ 36,445 ​ 323 ​ (1,474) ​ 35,294 ​ Collateralized mortgage obligations ​ 30,602 ​ 96 ​ (1,277) ​ 29,421 ​ SBA securities ​ 5,680 ​ 36 ​ (64) ​ 5,652 ​ Corporate bonds ​ 75,150 ​ 356 ​ (1,937) ​ 73,569 ​ Total ​ $ 172,927 ​ $ 867 ​ $ (5,819) ​ $ 167,975 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ ​ cost ​ gains ​ losses ​ fair value December 31, 2021 ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,510 ​ $ — ​ $ — ​ $ 1,510 Municipal securities ​ 23,646 ​ 493 ​ (16) ​ 24,123 Mortgage-backed securities ​ 33,973 ​ 1,333 ​ (210) ​ 35,096 Collateralized mortgage obligations ​ 27,228 ​ 436 ​ (158) ​ 27,506 SBA securities ​ 6,055 ​ 53 ​ (20) ​ 6,088 Corporate bonds ​ 60,650 ​ 851 ​ (166) ​ 61,335 Total ​ $ 153,062 ​ $ 3,166 ​ $ (570) ​ $ 155,658
Schedule of available-for-sale securities, continuous unrealized loss position, fair value	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Less than 12 months ​ 12 months or more ​ Total ​ Estimated Unrealized Estimated Unrealized Estimated Unrealized ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss March 31, 2022 (As Restated) ​ ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,508 ​ $ (1) ​ $ — ​ $ — ​ $ 1,508 ​ $ (1) Municipal securities ​ ​ 14,198 ​ ​ (1,066) ​ ​ — ​ ​ — ​ ​ 14,198 ​ ​ (1,066) Mortgage-backed securities ​ ​ 18,877 ​ ​ (1,076) ​ ​ 2,740 ​ ​ (398) ​ ​ 21,617 ​ ​ (1,474) Collateralized mortgage obligations ​ 18,474 ​ ​ (1,092) ​ ​ 2,059 ​ ​ (185) ​ 20,533 ​ (1,277) SBA securities ​ 1,194 ​ ​ (44) ​ ​ 976 ​ ​ (20) ​ 2,170 ​ (64) Corporate bonds ​ 50,313 ​ ​ (1,937) ​ ​ — ​ ​ — ​ 50,313 ​ (1,937) Total ​ $ 104,564 ​ $ (5,216) ​ $ 5,775 ​ $ (603) ​ $ 110,339 ​ $ (5,819) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Less than 12 months ​ 12 months or more ​ Total ​ Estimated Unrealized Estimated Unrealized Estimated Unrealized ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss December 31, 2021 ​ ​ ​ ​ ​ ​ ​ Municipal securities ​ $ 3,932 ​ $ (16) ​ $ — ​ $ — ​ $ 3,932 ​ $ (16) Mortgage-backed securities ​ 2,954 ​ (111) ​ 2,133 ​ (99) ​ 5,087 ​ (210) Collateralized mortgage obligations ​ 9,236 ​ (108) ​ 1,605 ​ (50) ​ 10,841 ​ (158) SBA securities ​ 134 ​ — ​ 1,058 ​ (20) ​ 1,192 ​ (20) Corporate bonds ​ 23,084 ​ (166) ​ — ​ — ​ 23,084 ​ (166) Total ​ $ 39,340 ​ $ (401) ​ $ 4,796 ​ $ (169) ​ $ 44,136 ​ $ (570)
Schedule of investments classified by contractual maturity date	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 ​ December 31, 2021 ​ Amortized Estimated Amortized Estimated ​ ​ cost ​ fair value ​ cost ​ fair value ​ ​ (As Restated) ​ (As Restated) ​ ​ ​ ​ ​ ​ Available-for-sale ​ ​ ​ ​ Due in one year or less ​ $ 861 ​ $ 861 ​ $ 862 ​ $ 865 Due after one through five years ​ 23,297 ​ 23,229 ​ 23,519 ​ 24,173 Due after five years through ten years ​ 88,707 ​ 85,952 ​ 79,116 ​ 79,993 Due after ten years ​ 60,062 ​ 57,933 ​ 49,565 ​ 50,627 Total ​ $ 172,927 ​ $ 167,975 ​ $ 153,062 ​ $ 155,658

LOANS (Tables)

LOANS (Tables)	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Schedule of accounts, notes, loans and financing receivable	The Company’s loan portfolio at the dates indicated is summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Commercial and industrial ​ $ 313,556 ​ $ 230,177 Construction and land ​ 20,854 ​ 13,371 Commercial real estate ​ 1,564,305 ​ 1,299,684 Residential ​ 102,079 ​ 118,423 Consumer ​ 3,675 ​ 5,138 Total loans ​ 2,004,469 ​ 1,666,793 Net deferred loan fees ​ (541) ​ (1,903) Allowance for loan losses ​ (17,700) ​ (17,700) Net loans ​ $ 1,986,228 ​ $ 1,647,190
Schedule of impaired financing receivables	The Company’s total impaired loans, including nonaccrual loans TDR loans, and accreting purchase credit impaired (“PCI”) loans that have experienced post-acquisition declines in cash flows expected to be collected are summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial Construction Commercial ​ ​ ​ ​ ​ and industrial ​ and land ​ real estate ​ Residential ​ Consumer ​ Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ Recorded investment in impaired loans: ​ ​ ​ ​ ​ ​ With no specific allowance recorded ​ $ 184 ​ $ 36 ​ $ 5,451 ​ $ 1,632 ​ $ — ​ $ 7,303 With a specific allowance recorded ​ 5,538 ​ — ​ 259 ​ 128 ​ — ​ 5,925 Total recorded investment in impaired loans ​ $ 5,722 ​ $ 36 ​ $ 5,710 ​ $ 1,760 ​ $ — ​ $ 13,228 Specific allowance on impaired loans ​ $ 1,277 ​ $ — ​ $ 259 ​ $ 10 ​ $ — ​ 1,546 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ ​ ​ ​ Recorded investment in impaired loans: ​ ​ ​ ​ ​ ​ With no specific allowance recorded ​ $ 112 ​ $ 36 ​ $ 5,015 ​ $ 1,441 ​ $ — ​ $ 6,604 With a specific allowance recorded ​ 681 ​ — ​ 262 ​ 146 ​ — ​ 1,089 Total recorded investment in impaired loans ​ $ 793 ​ $ 36 ​ $ 5,277 ​ $ 1,587 ​ $ — ​ $ 7,693 Specific allowance on impaired loans ​ $ 681 ​ $ — ​ $ 224 ​ $ 25 ​ $ — ​ $ 930 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2022 ​ ​ ​ ​ ​ ​ Average recorded investment in impaired loans ​ $ 3,237 ​ $ 812 ​ $ 5,493 ​ $ 898 ​ $ — ​ $ 10,440 Interest recognized ​ 1 ​ — ​ 6 ​ 8 ​ — ​ 15 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended March 31, 2021 ​ ​ ​ ​ ​ ​ Average recorded investment in impaired loans ​ 915 ​ 36 ​ 6,073 ​ 2,628 ​ — ​ 9,652 Interest recognized ​ 1 ​ — ​ 58 ​ 4 ​ — ​ 63
Schedule of debtor troubled debt restructuring, current period	A summary of TDR loans by type of concession and type of loan, as of the periods indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of Rate Term Rate & term ​ ​ ​ loans ​ modification ​ modification ​ modification ​ Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial 3 ​ $ — ​ $ 4,881 ​ $ — ​ $ 4,881 Construction and land — ​ — ​ — ​ — ​ — Commercial real estate 4 ​ — ​ 2,191 ​ — ​ 2,191 Residential 1 ​ — ​ ​ 128 ​ — ​ 128 Consumer — ​ — ​ — ​ — ​ — Total 8 ​ $ — ​ $ 7,200 ​ $ — ​ $ 7,200 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of Rate Term Rate & term ​ ​ ​ loans ​ modification ​ modification ​ modification ​ Total March 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial 2 ​ $ — ​ $ 29 ​ $ — ​ $ 29 Construction and land — ​ — ​ — ​ — ​ — Commercial real estate 3 ​ — ​ 1,422 ​ — ​ 1,422 Residential 1 ​ — ​ 150 ​ — ​ 150 Consumer — ​ — ​ — ​ — ​ — Total 6 ​ $ — ​ $ 1,601 ​ $ — ​ $ 1,601
Schedule of financing receivable credit quality indicators	The following tables present the internally assigned risk grade by class of loans at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Special ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ Mention ​ Substandard ​ Doubtful ​ Total March 31, 2022 ​ ​ ​ ​ ​ Commercial and industrial ​ $ 300,516 ​ $ 3,740 ​ $ 9,300 ​ $ — ​ $ 313,556 Construction and land ​ 17,830 ​ 2,988 ​ 36 ​ — ​ 20,854 Commercial real estate ​ 1,505,699 ​ 53,433 ​ 5,173 ​ — ​ 1,564,305 Residential ​ 98,742 ​ 1,527 ​ 1,810 ​ — ​ 102,079 Consumer ​ 3,653 ​ — ​ 22 ​ — ​ 3,675 Total ​ $ 1,926,440 ​ $ 61,688 ​ $ 16,341 ​ $ — ​ $ 2,004,469 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Special ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ Mention ​ Substandard ​ Doubtful ​ Total December 31, 2021 ​ ​ ​ ​ ​ Commercial and industrial ​ $ 216,611 ​ $ 9,178 ​ $ 4,388 ​ $ — ​ $ 230,177 Construction and land ​ 13,264 ​ 71 ​ 36 ​ — ​ 13,371 Commercial real estate ​ 1,264,269 ​ 28,438 ​ 6,977 ​ — ​ 1,299,684 Residential ​ 115,534 ​ 1,250 ​ 1,639 ​ — ​ 118,423 Consumer ​ 5,116 ​ — ​ 22 ​ — ​ 5,138 Total ​ $ 1,614,794 ​ $ 38,937 ​ $ 13,062 ​ $ — ​ $ 1,666,793
Schedule of past due financing receivables	The following tables provide an aging of the Company’s loans receivable as of the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Recorded ​ ​ ​ ​ ​ 90 Days ​ ​ ​ ​ ​ ​ ​ ​ investment > ​ ​ 30–59 Days ​ 60–89 Days ​ or more ​ Total ​ ​ ​ ​ ​ ​ ​ Total loans ​ 90 days and ​ ​ past due ​ past due ​ past due ​ past due ​ Current ​ PCI loans ​ receivable ​ accruing March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial ​ $ 5,828 ​ $ 236 ​ $ 653 ​ $ 6,717 ​ $ 302,380 ​ $ 4,459 ​ $ 313,556 ​ $ — Construction and land ​ 337 ​ — ​ 36 ​ 373 ​ 19,034 ​ 1,447 ​ 20,854 ​ — Commercial real estate ​ 109 ​ 697 ​ 3,119 ​ 3,925 ​ 1,536,959 ​ 23,421 ​ 1,564,305 ​ — Residential ​ 729 ​ 321 ​ ​ 1,002 ​ 2,052 ​ 98,457 ​ 1,570 ​ 102,079 ​ 117 Consumer ​ — ​ 221 ​ — ​ 221 ​ 3,454 ​ — ​ 3,675 ​ — Total ​ $ 7,003 ​ $ 1,475 ​ $ 4,810 ​ $ 13,288 ​ $ 1,960,284 ​ $ 30,897 ​ $ 2,004,469 ​ $ 117 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Recorded ​ ​ ​ ​ ​ 90 Days ​ ​ ​ ​ ​ ​ ​ ​ investment > ​ ​ 30–59 Days ​ 60–89 Days ​ or more ​ Total ​ ​ ​ ​ ​ ​ ​ Total loans ​ 90 days and ​ ​ past due ​ past due ​ past due ​ past due ​ Current ​ PCI loans ​ receivable ​ accruing December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ Commercial and industrial ​ $ 275 ​ $ 10 ​ $ 606 ​ $ 891 ​ $ 228,980 ​ $ 306 ​ $ 230,177 ​ $ — Construction and land ​ — ​ 338 ​ 36 ​ 374 ​ 12,997 ​ — ​ 13,371 ​ — Commercial real estate ​ 196 ​ 410 ​ 2,621 ​ 3,227 ​ 1,286,311 ​ 10,146 ​ 1,299,684 ​ — Residential ​ 1,442 ​ 21 ​ 1,031 ​ 2,494 ​ 114,162 ​ 1,767 ​ 118,423 ​ — Consumer ​ 3 ​ — ​ — ​ 3 ​ 5,135 ​ — ​ 5,138 ​ — Total ​ $ 1,916 ​ $ 779 ​ $ 4,294 ​ $ 6,989 ​ $ 1,647,585 ​ $ 12,219 ​ $ 1,666,793 ​ $ —
Schedule of purchase credit impaired loans	The unpaid principal balance and carrying value of the Company’s PCI loans at the dates indicated are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2022 ​ December 31, 2021 ​ Unpaid ​ ​ Unpaid ​ ​ ​ ​ principal ​ Carrying ​ principal ​ Carrying ​ ​ balance ​ value ​ balance ​ value Commercial and industrial ​ $ 5,587 ​ $ 4,459 ​ $ 546 ​ $ 306 Construction and land ​ 1,667 ​ 1,447 ​ — ​ — Commercial real estate ​ 25,751 ​ ​ 23,421 ​ 11,519 ​ 10,146 Residential ​ 1,943 ​ 1,570 ​ 2,202 ​ 1,767 Total ​ $ 34,948 ​ $ 30,897 ​ $ 14,267 ​ $ 12,219
Schedule of changes in the accretable yield of PCI loans	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ ​ 2022 ​ 2021 ​ Balance at beginning of period ​ $ 508 ​ $ 383 ​ Additions ​ 1,277 ​ — ​ Removals ​ (48) ​ (65) ​ Accretion ​ (50) ​ (230) ​ Balance at end of period ​ $ 1,687 ​ $ 88 ​

ALLOWANCE FOR LOAN LOSSES (Tabl

ALLOWANCE FOR LOAN LOSSES (Tables)	3 Months Ended
	Mar. 31, 2022
Allowance for Loan Losses [Abstract]
Schedule of Allowance for credit losses for loan losses	The following tables summarize the Company’s allowance for loan losses and loan balances individually and collectively evaluated for impairment by type of loan as of or for the three months ended March 31, 2022 and 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial ​ Construction ​ Commercial ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ and industrial and land real estate Residential Consumer Total March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses ​ ​ ​ ​ ​ ​ Beginning balance ​ $ 3,261 ​ $ 175 ​ $ 12,709 ​ $ 1,536 ​ $ 19 ​ $ 17,700 Charge-offs ​ — ​ — ​ (1) ​ (6) ​ (3) ​ (10) Recoveries ​ 3 ​ — ​ — ​ — ​ — ​ 3 Provision for (reversal of) loan losses ​ 235 ​ ​ (37) ​ ​ 264 ​ ​ (457) ​ ​ 2 ​ 7 Ending balance ​ $ 3,499 ​ $ 138 ​ $ 12,972 ​ $ 1,073 ​ $ 18 ​ $ 17,700 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses by methodology: ​ ​ ​ ​ ​ ​ Loans individually evaluated for impairment ​ $ 1,277 ​ $ — ​ $ 259 ​ $ 128 ​ $ — ​ $ 1,664 Loans collectively evaluated for impairment ​ 2,222 ​ 138 ​ 12,713 ​ 945 ​ 18 ​ 16,036 PCI loans ​ — ​ — ​ — ​ — ​ — ​ — ​ ​ ​ ​ ​ ​ ​ Loans receivable by methodology: ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 5,723 ​ $ 36 ​ $ 5,710 ​ $ 1,759 ​ $ — ​ $ 13,228 Collectively evaluated for impairment ​ 303,374 ​ 19,371 ​ 1,535,174 ​ 98,750 ​ 3,675 ​ 1,960,344 PCI loans ​ 4,459 ​ 1,447 ​ 23,421 ​ 1,570 ​ — ​ 30,897 Total loans ​ $ 313,556 ​ $ 20,854 ​ $ 1,564,305 ​ $ 102,079 ​ $ 3,675 ​ $ 2,004,469 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial ​ Construction ​ Commercial ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ and industrial and land real estate Residential Consumer Total March 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses ​ ​ ​ ​ ​ ​ Beginning balance ​ $ 4,042 ​ $ 378 ​ $ 11,211 ​ $ 1,856 ​ $ 13 ​ $ 17,500 Charge-offs ​ (2) ​ — ​ — ​ — ​ — ​ (2) Recoveries ​ 2 ​ — ​ — ​ — ​ — ​ 2 Provision for (reversal of) loan losses ​ (223) ​ ​ (113) ​ ​ 36 ​ ​ 291 ​ ​ 9 ​ — Ending balance ​ $ 3,819 ​ $ 265 ​ $ 11,247 ​ $ 2,147 ​ $ 22 ​ $ 17,500 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for loan losses by methodology: ​ ​ ​ ​ ​ ​ Loans individually evaluated for impairment ​ $ 490 ​ $ — ​ $ 116 ​ $ 20 ​ $ — ​ $ 626 Loans collectively evaluated for impairment ​ 3,218 ​ 265 ​ 11,131 ​ 2,127 ​ 22 ​ 16,763 PCI loans ​ 111 ​ — ​ — ​ — ​ — ​ 111 ​ ​ ​ ​ ​ ​ ​ ​ Loans receivable by methodology: ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 978 ​ $ 36 ​ $ 6,079 ​ $ 3,524 ​ $ — ​ $ 10,617 Collectively evaluated for impairment ​ 322,330 ​ 14,539 ​ 1,078,547 ​ 141,909 ​ 6,832 ​ 1,564,157 PCI loans ​ 638 ​ 48 ​ 11,135 ​ 2,252 ​ — ​ 14,073 Total loans ​ $ 323,946 ​ $ 14,623 ​ $ 1,095,761 ​ $ 147,685 ​ $ 6,832 ​ $ 1,588,847

PREMISES AND EQUIPMENT (Tables)

PREMISES AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of premises and equipment	Premises and equipment consisted of the following at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Premises owned ​ $ 11,115 ​ $ 11,015 Leasehold improvements ​ 2,619 ​ 2,608 Furniture, fixtures and equipment ​ 6,462 ​ 6,201 Less accumulated depreciation and amortization ​ (5,939) ​ (5,454) Total premises and equipment, net ​ $ 14,257 ​ $ 14,370

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of maturity of undiscounted lease payments	​ ​ ​ ​ ​ For remainder of 2022 ​ $ 3,832 2023 ​ 3,466 2024 ​ 2,952 2025 ​ 2,039 2026 ​ ​ 1,296 Thereafter ​ 2,563 Total undiscounted cash flows ​ ​ 16,148 Less: interest ​ ​ (1,971) Present value of lease payments ​ $ 14,177
Schedule of weighted average operating lease term and discount rate	​ ​ ​ ​ ​ ​ March 31, 2022 Weighted-average remaining lease term 5.1 years Weighted-average discount rate 2.41 %

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of company's goodwill	​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Balance at beginning of period ​ $ 38,838 ​ $ 38,838 Acquired goodwill ​ — ​ — Impairment ​ — ​ — Balance at end of period ​ $ 38,838 ​ $ 38,838
Schedule of finite-lived intangible assets	​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Balance at beginning of period ​ $ 6,489 ​ $ 8,302 Additions ​ 756 ​ — Less amortization ​ (495) ​ (1,813) Balance at end of period ​ $ 6,750 ​ $ 6,489
Schedule of estimated core deposit intangible amortization	​ ​ ​ ​ ​ For remainder of 2022 ​ $ 1,549 2023 ​ 1,286 2024 ​ 1,222 2025 ​ 948 2026 ​ ​ 455 Thereafter ​ 1,290 Total ​ $ 6,750

INTEREST RECEIVABLE AND OTHER_2

INTEREST RECEIVABLE AND OTHER ASSETS (Tables)	3 Months Ended
	Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Interest receivable and other assets	The Company’s interest receivable and other assets at the dates indicated consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Tax assets, net ​ $ 11,391 ​ $ 10,573 Accrued interest receivable ​ 8,262 ​ 5,929 Investment in Small Business Investment Company ("SBIC") fund ​ 4,929 ​ 4,731 Investment in Community Reinvestment Act fund ​ ​ 2,000 ​ ​ — Prepaid assets ​ 1,076 ​ 1,598 Servicing assets ​ 2,365 ​ 1,947 Investment in Low Income Housing Tax Credit ("LIHTC") partnerships, net ​ 2,981 ​ 3,129 Investment in statutory trusts ​ 485 ​ 484 Other assets ​ 5,644 ​ 1,469 Total ​ $ 39,133 ​ $ 29,860

DEPOSITS (Tables)

DEPOSITS (Tables)	3 Months Ended
	Mar. 31, 2022
Deposits [Abstract]
Schedule of Deposits	The Company’s deposits consisted of the following at the dates indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Demand deposits ​ $ 783,110 ​ $ 710,137 NOW accounts and savings ​ 476,077 ​ 484,847 Money market ​ 760,359 ​ 568,094 Time deposits ​ 310,849 ​ 222,161 Total ​ $ 2,330,395 ​ $ 1,985,239

INTEREST PAYABLE AND OTHER LI_2

INTEREST PAYABLE AND OTHER LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2022
Other Liabilities Disclosure [Abstract]
Schedule of interest payable and other liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Accrued expenses ​ $ 5,634 ​ $ 7,339 Accounts payable ​ 412 ​ 506 Reserve for unfunded commitments ​ 315 ​ 315 Accrued interest payable ​ 344 ​ 1,180 Other liabilities ​ 3,557 ​ 4,516 Total ​ $ 10,262 ​ $ 13,856

OTHER EXPENSES (Tables)

OTHER EXPENSES (Tables)	3 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
Schedule of other expenses	The Company’s other expenses for the periods indicated consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2022 ​ 2021 ​ Professional fees ​ $ 1,306 ​ $ 434 ​ Core deposit premium amortization ​ 495 ​ 454 ​ Marketing and promotions ​ 296 ​ 64 ​ Stationery and supplies ​ 92 ​ 107 ​ Insurance (including FDIC premiums) ​ 231 ​ 210 ​ Communication and postage ​ 224 ​ 214 ​ Loan default related expense ​ 39 ​ 14 ​ Director fees ​ 84 ​ 76 ​ Bank service charges ​ 66 ​ 56 ​ Courier expense ​ 175 ​ 176 ​ Other ​ 304 ​ 96 ​ Total ​ $ 3,312 ​ $ 1,901 ​

EQUITY INCENTIVE PLANS (Tables)

EQUITY INCENTIVE PLANS (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of nonvested restricted stock units activity	The following table provides the restricted stock grant activity for the periods indicated: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 ​ 2021 ​ ​ ​ Weighted-average ​ Weighted-average ​ ​ ​ ​ grant date ​ ​ ​ grant date ​ ​ Shares ​ fair value ​ Shares ​ fair value Non-vested at January 1, 139,275 ​ $ 16.29 ​ 204,515 ​ $ 17.71 ​ Granted 22,473 ​ 18.79 ​ 24,187 ​ 15.17 ​ Vested (15,560) ​ 18.34 ​ (14,164) ​ 18.50 ​ Forfeited ​ (532) ​ ​ 18.79 ​ — ​ ​ — ​ Non-Vested, at March 31, 145,656 ​ $ 16.45 ​ 214,538 ​ $ 16.06 ​

FAIR VALUE MEASUREMENT (Tables)

FAIR VALUE MEASUREMENT (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value, assets measured on recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,508 ​ $ — ​ $ 1,508 ​ $ — Municipal securities ​ 22,531 ​ — ​ 22,531 ​ — Mortgage-backed securities ​ 35,294 ​ — ​ 35,294 ​ — Collateralized mortgage obligations ​ 29,421 ​ — ​ 29,421 ​ — SBA securities ​ 5,652 ​ — ​ 5,652 ​ — Corporate bonds ​ 73,569 ​ — ​ 73,569 ​ — Equity securities ​ ​ 16,698 ​ ​ 16,698 ​ ​ — ​ ​ — Total ​ $ 184,673 ​ $ 16,698 ​ $ 167,975 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ U.S. Government Agencies ​ $ 1,510 ​ $ — ​ $ 1,510 ​ $ — Municipal securities ​ 24,123 ​ — ​ 24,123 ​ — Mortgage-backed securities ​ 35,096 ​ — ​ 35,096 ​ — Collateralized mortgage obligations ​ 27,506 ​ — ​ 27,506 ​ — SBA securities ​ 6,088 ​ — ​ 6,088 ​ — Corporate bonds ​ 61,335 ​ — ​ 61,335 ​ — Equity securities ​ ​ 18,777 ​ ​ 18,777 ​ ​ — ​ ​ — Total ​ $ 174,435 ​ $ 18,777 ​ $ 155,658 ​ $ —
Schedule of fair value measurements, nonrecurring	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ Performing impaired loans ​ $ 794 ​ $ — ​ $ — ​ $ 794 Nonperforming impaired loans ​ 12,434 ​ — ​ — ​ 12,434 OREO ​ 21 ​ — ​ — ​ 21 Total ​ $ 13,249 ​ $ — ​ $ — ​ $ 13,249 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ Performing impaired loans ​ $ 805 ​ $ — ​ $ — ​ $ 805 Nonperforming impaired loans ​ 6,888 ​ — ​ — ​ 6,888 OREO ​ 21 ​ — ​ — ​ 21 Total ​ $ 7,714 ​ $ — ​ $ — ​ $ 7,714

FAIR VALUE OF FINANCIAL INSTR_2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of estimated fair value of financial instruments	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Fair ​ Fair value measurements ​ amount value Level 1 Level 2 Level 3 March 31, 2022 ​ ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 427,199 ​ $ 427,199 ​ $ 427,199 ​ $ — ​ $ — Interest bearing deposits in banks ​ 3,336 ​ 3,336 ​ 3,336 ​ — ​ — Investment securities available-for-sale ​ 167,975 ​ 167,975 ​ — ​ 167,975 ​ — Equity securities ​ ​ 16,698 ​ ​ 16,698 ​ ​ 16,698 ​ ​ — ​ ​ — Investment in FHLB and FRB Stock ​ 19,226 ​ 19,226 ​ 19,226 ​ — ​ — Loans held for sale ​ 970 ​ 970 ​ — ​ 970 ​ — Loans, net ​ 1,986,228 ​ 1,991,792 ​ — ​ — ​ 1,991,792 Accrued interest receivable ​ 8,262 ​ 8,262 ​ — ​ 8,262 ​ — Financial liabilities: ​ ​ ​ ​ ​ Deposits ​ 2,330,395 ​ 2,332,443 ​ — ​ 2,332,443 ​ — Junior subordinated deferrable interest debentures, net ​ ​ 8,423 ​ ​ 8,640 ​ ​ — ​ ​ — ​ ​ 8,640 Subordinated debt, net ​ ​ 63,584 ​ 63,584 ​ — ​ ​ 63,584 ​ ​ — Accrued interest payable ​ 344 ​ 344 ​ — ​ 344 ​ — Off-balance sheet liabilities: ​ ​ ​ ​ ​ ​ Undisbursed loan commitments, lines of credit, standby letters of credit ​ 89,054 ​ 88,739 ​ — ​ — ​ 88,739 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Fair ​ Fair value measurements ​ amount value Level 1 Level 2 Level 3 December 31, 2021 ​ ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 379,687 ​ $ 379,687 ​ $ 379,687 ​ $ — ​ $ — Interest bearing deposits in banks ​ 3,585 ​ 3,585 ​ 3,585 ​ — ​ — Investment securities available-for-sale ​ 155,658 ​ 155,658 ​ — ​ 155,658 ​ — Equity securities ​ ​ 18,777 ​ ​ 18,777 ​ ​ 18,777 ​ ​ ​ ​ ​ ​ Investment in FHLB and FRB Stock ​ 16,035 ​ 16,035 ​ 16,035 ​ — ​ — Loans held for sale ​ 6,470 ​ 6,470 ​ — ​ 6,470 ​ — Loans, net ​ 1,647,190 ​ 1,659,811 ​ — ​ — ​ 1,659,811 Accrued interest receivable ​ 5,929 ​ 5,929 ​ — ​ 5,929 ​ — Financial liabilities: ​ ​ ​ ​ ​ Deposits ​ 1,985,239 ​ 1,986,651 ​ — ​ 1,986,651 ​ — Junior subordinated deferrable interest debentures, net ​ 8,403 ​ 8,612 ​ — ​ — ​ 8,612 Subordinated debt, net ​ 63,542 ​ 63,542 ​ — ​ 63,542 ​ — Accrued interest payable ​ 1,180 ​ 1,180 ​ — ​ 1,180 ​ — Off-balance sheet liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Undisbursed loan commitments, lines of credit, standby letters of credit ​ 104,139 ​ 103,824 ​ — ​ — ​ 103,824

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of lending and letter of credit commitments	​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, December 31, ​ ​ 2022 ​ 2021 Commitments to extend credit ​ $ 86,292 ​ $ 100,686 Standby letters of credit ​ 2,762 ​ 3,453 Total commitments ​ $ 89,054 ​ $ 104,139

BASIS OF PRESENTATION - General

BASIS OF PRESENTATION - General Information (Details)	3 Months Ended
	Mar. 31, 2022 location
Years of operation	17 years
Number of offices and branches	34
CALIFORNIA
Number of offices and branches	16
WASHINGTON
Number of offices and branches	2
NEW MEXICO
Number of offices and branches	5
COLORADO
Number of offices and branches	11

BASIS OF PRESENTATION- Business

BASIS OF PRESENTATION- Business Combinations (Details)	Feb. 01, 2022
Pacific Enterprise Bancorp
Business Acquisition, Date of Acquisition [Abstract]
Business Acquisition, Effective Date of Acquisition	Feb. 01, 2022

ACCOUNTING GUIDANCE NOT YET E_2

ACCOUNTING GUIDANCE NOT YET EFFECTIVE AND ADOPTED ACCOUNTING GUIDANCE (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings	$ 107,600	$ 103,056
Accounting Standards Update 2016-13
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted	false
Accounting Standards Update 2020-04 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted	false
Accounting Standards Update 2022-02 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted	false

RESTATEMENT OF THE CONSOLIDAT_3

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($)
Prior Period Adjustment [Abstract]
Fair value of preferred equity securities	$ 1.3

RESTATEMENT OF THE CONSOLIDAT_4

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash and due from banks	$ 35,532	$ 21,178
Federal funds sold	391,667	358,509
Cash and cash equivalents	427,199	379,687
Interest bearing deposits in banks	3,336	3,585
Investment securities available-for-sale (AFS)	167,975	155,658
Equity securities	16,698	18,777
Federal Home Loan Bank ("FHLB") stock, at par	10,679	8,385
Federal Reserve Bank ("FRB") stock, at par	8,547	7,650
Loans held for sale	970	6,470
Loans, net of allowance for credit losses	1,986,228	1,647,190
Premises and equipment, net	14,257	14,370
Other real estate owned ("OREO")	21	21
Core deposit intangible, net	6,750	6,489
Cash surrender value of bank owned life insurance ("BOLI") policies, net	21,736	21,590
Right-of-use assets ("ROU"), net	13,645	12,127
Goodwill	38,838	38,838		$ 38,838
Interest receivable and other assets	39,133	29,860
Total assets	2,756,012	2,350,697
LIABILITIES AND SHAREHOLDERS' EQUITY
Noninterest and interest bearing deposits	2,330,395	1,985,239
Junior subordinated deferrable interest debentures, net	8,423	8,403
Subordinated debt, net	63,584	63,542
Salary continuation plan	4,517	4,393
Lease liabilities	14,177	12,657
Interest payable and other liabilities	10,262	13,856
Total liabilities	2,431,358	2,088,090
Commitments and contingencies (Note 19)
Shareholders' equity
Preferred stock
Common stock	220,294	157,098
Additional paid in capital	287	287
Accumulated other comprehensive loss, net of tax	(3,527)	2,166
Retained earnings	107,600	103,056
Total shareholders' equity	324,654	262,607	$ 254,550	$ 252,591
Total liabilities and shareholders' equity	2,756,012	$ 2,350,697
Previously Reported
ASSETS
Cash and due from banks	35,532
Federal funds sold	391,667
Cash and cash equivalents	427,199
Interest bearing deposits in banks	3,336
Investment securities available-for-sale (AFS)	184,673
Federal Home Loan Bank ("FHLB") stock, at par	10,679
Federal Reserve Bank ("FRB") stock, at par	8,547
Loans held for sale	970
Loans, net of allowance for credit losses	1,986,228
Premises and equipment, net	14,257
Other real estate owned ("OREO")	21
Core deposit intangible, net	6,750
Cash surrender value of bank owned life insurance ("BOLI") policies, net	21,736
Right-of-use assets ("ROU"), net	13,645
Goodwill	38,838
Interest receivable and other assets	39,133
Total assets	2,756,012
LIABILITIES AND SHAREHOLDERS' EQUITY
Noninterest and interest bearing deposits	2,330,395
Junior subordinated deferrable interest debentures, net	8,423
Subordinated debt, net	63,584
Salary continuation plan	4,517
Lease liabilities	14,177
Interest payable and other liabilities	10,262
Total liabilities	2,431,358
Commitments and contingencies (Note 19)
Shareholders' equity
Preferred stock
Common stock	220,294
Additional paid in capital	287
Accumulated other comprehensive loss, net of tax	(4,786)
Retained earnings	108,859
Total shareholders' equity	324,654
Total liabilities and shareholders' equity	2,756,012
Revision of Prior Period, Adjustment
ASSETS
Investment securities available-for-sale (AFS)	(16,698)
Equity securities	16,698
LIABILITIES AND SHAREHOLDERS' EQUITY
Commitments and contingencies (Note 19)
Shareholders' equity
Preferred stock
Accumulated other comprehensive loss, net of tax	1,259
Retained earnings	$ (1,259)

RESTATEMENT OF THE CONSOLIDAT_5

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Balance Sheet (Parenthetical) (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Allowance for loan losses
Investment securities available-for-sale amortized cost	$ 172,927	$ 153,062
Allowance for loan losses	$ 17,700	$ 17,700	$ 17,500	$ 17,500
Preferred Stock
Preferred Stock, No Par Value	$ 0	$ 0
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock
Common Stock, No Par Value	$ 0	$ 0
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	13,677,729	10,680,386
Common Stock, Shares, Outstanding	13,677,729	10,680,386

RESTATEMENT OF THE CONSOLIDAT_6

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Statement of Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest income:
Loans, including fees	$ 22,927	$ 19,193
Investment securities and interest bearing deposits in banks	1,608	868
FHLB dividends	149	99
FRB dividends	121	112
Total interest and dividend income	24,805	20,272
Interest expense:
Deposits	1,470	1,206
Subordinated debt	896	895
Other borrowings	86	87
Total interest expense	2,452	2,188
Net interest income	22,353	18,084
Provision for credit losses	7	0
Net interest income after provision for credit losses	22,346	18,084
Noninterest income:
Gain on sale of loans	1,137	576
Loss on equity securities	(1,768)
Loan servicing and other loan fees	574	529
Income on investment in Small Business Investment Company ("SBIC") fund	197	263
Gain on sale of OREO		36
Bargain purchase gain	1,665
Other income and fees	196	229
Total noninterest income	2,631	2,237
Noninterest expense:
Salaries and employee benefits	10,310	8,885
Occupancy and equipment	2,426	1,815
Data processing	2,273	1,484
Other expense	3,312	1,901
Total noninterest expense	18,321	14,085
Income before provision for income taxes	6,656	6,236
Provision for income taxes	1,427	1,704
Net income	$ 5,229	$ 4,532
Earnings per common share:
Basic earnings per common share (in dollars per share)	$ 0.41	$ 0.40
Weighted average shares outstanding (in shares)	12,646,981	11,273,604
Diluted earnings per common share (in dollars per share)	$ 0.41	$ 0.40
Weighted average shares outstanding (in shares)	12,646,981	11,273,604
Service charges and other fees
Noninterest income:
Service charges and other fees	$ 630	$ 604
Previously Reported
Interest income:
Loans, including fees	22,927
Investment securities and interest bearing deposits in banks	1,608
FHLB dividends	149
FRB dividends	121
Total interest and dividend income	24,805
Interest expense:
Deposits	1,470
Subordinated debt	896
Other borrowings	86
Total interest expense	2,452
Net interest income	22,353
Provision for credit losses	7
Net interest income after provision for credit losses	22,346
Noninterest income:
Gain on sale of loans	1,137
Loan servicing and other loan fees	574
Income on investment in Small Business Investment Company ("SBIC") fund	197
Bargain purchase gain	1,665
Other income and fees	196
Total noninterest income	4,399
Noninterest expense:
Salaries and employee benefits	10,310
Occupancy and equipment	2,426
Data processing	2,273
Other expense	3,312
Total noninterest expense	18,321
Income before provision for income taxes	8,424
Provision for income taxes	1,936
Net income	$ 6,488
Earnings per common share:
Basic earnings per common share (in dollars per share)	$ 0.51
Weighted average shares outstanding (in shares)	12,646,981
Diluted earnings per common share (in dollars per share)	$ 0.51
Weighted average shares outstanding (in shares)	12,646,981
Previously Reported | Service charges and other fees
Noninterest income:
Service charges and other fees	$ 630
Revision of Prior Period, Adjustment
Noninterest income:
Loss on equity securities	(1,768)
Total noninterest income	(1,768)
Noninterest expense:
Income before provision for income taxes	(1,768)
Provision for income taxes	(509)
Net income	$ (1,259)
Earnings per common share:
Basic earnings per common share (in dollars per share)	$ (0.10)
Weighted average shares outstanding (in shares)	12,646,981
Diluted earnings per common share (in dollars per share)	$ (0.10)
Weighted average shares outstanding (in shares)	12,646,981

RESTATEMENT OF THE CONSOLIDAT_7

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Statement of Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net income
Net income	$ 5,229	$ 4,532
Other comprehensive loss:
Change in unrealized loss on available-for-sale securities	(7,993)	(1,101)
Deferred tax benefit	2,300	316
Other comprehensive loss, net of tax	(5,693)	(785)
Total comprehensive income (loss)	(464)	$ 3,747
Previously Reported
Net income
Net income	6,488
Other comprehensive loss:
Change in unrealized loss on available-for-sale securities	(9,761)
Deferred tax benefit	2,809
Other comprehensive loss, net of tax	(6,952)
Total comprehensive income (loss)	(464)
Revision of Prior Period, Adjustment
Net income
Net income	(1,259)
Other comprehensive loss:
Change in unrealized loss on available-for-sale securities	1,768
Deferred tax benefit	(509)
Other comprehensive loss, net of tax	$ 1,259

RESTATEMENT OF THE CONSOLIDAT_8

RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Statement of Cash Flow Changes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 5,229	$ 4,532
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	7	0
Increase in deferred tax assets	2,309	(29)
Loss on equity securities	1,768
Net cash provided by operating activities	2,846	651
Non-cash investing and financing activities:
Change in unrealized loss on available-for-sale securities, net of tax	(5,693)	$ (785)
Previously Reported
Cash flows from operating activities:
Net income	6,488
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	7
Increase in deferred tax assets	2,818
Net cash provided by operating activities	2,846
Non-cash investing and financing activities:
Change in unrealized loss on available-for-sale securities, net of tax	(6,952)
Revision of Prior Period, Adjustment
Cash flows from operating activities:
Net income	(1,259)
Adjustments to reconcile net income to net cash provided by operating activities:
Increase in deferred tax assets	(509)
Loss on equity securities	1,768
Non-cash investing and financing activities:
Change in unrealized loss on available-for-sale securities, net of tax	$ 1,259

ACQUISITIONS - General Informat

ACQUISITIONS - General Information (Details) $ in Thousands		3 Months Ended
	Feb. 01, 2022 USD ($) location shares	Mar. 31, 2022 USD ($) location	Mar. 31, 2021 USD ($)
Business Combination, Description [Abstract]
Number of offices and branches | location		34
Bargain purchase gain		$ 1,665
Acquisition related expenses		3,075	$ 0
Pacific Enterprise Bancorp [Member]
Business Combination, Description [Abstract]
Transaction value	$ 64,100
Number of offices and branches | location	1
Cash consideration	$ 275
Stock consideration | shares	3,032,579
Bargain purchase gain	$ 1,665	1,600
Acquisition related expenses		$ 3,100

ACQUISITIONS - Assets Acquired

ACQUISITIONS - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		3 Months Ended
	Feb. 01, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Liabilities:
Bargain purchase gain		$ 1,665
Goodwill		38,838	$ 38,838	$ 38,838
Tax effect of accounting adjustments, rate	27.90%
Previously Reported
Liabilities:
Bargain purchase gain		1,665
Goodwill		38,838
Pacific Enterprise Bancorp
Liabilities:
Fair value of net assets acquired	$ 61,469
Fair value of assets acquired	66,080
Value of stock issued/cash paid for stock options	64,415
Bargain purchase gain	1,665	$ 1,600
Pacific Enterprise Bancorp | Previously Reported
Fair value of assets:
Cash and due from banks	5,350
Total cash and cash equivalents	5,350
Interest bearing deposits in banks	13,348
Investment securities available-for-sale	3
FHLB stock, at par	2,294
FRB stock, at par	942
Loans, net	412,851
Premises and equipment, net	221
Core deposit intangible	756
Deferred tax assets, net	1,192
Interest receivable and other assets	9,178
Total assets acquired	446,135
Liabilities:
Noninterest bearing	60,006
Interest bearing	316,679
Total Deposits	376,685
Interest payable and other liabilities	3,370
Total liabilities assumed	380,055
Pacific Enterprise Bancorp | Revision of Prior Period, Adjustment
Fair value of assets:
Loans, net	5,840
Premises and equipment, net	26
Core deposit intangible	756
Time deposits	(869)
Reserve for unfunded commitments	283
Liabilities:
Write-up right-of-use asset	439
Fair value of net assets acquired	6,475
Tax effect of purchase accounting adjustments	$ (1,864)

ACQUISITIONS - Consideration Tr

ACQUISITIONS - Consideration Transferred (Details) - USD ($) $ in Thousands		3 Months Ended
	Feb. 01, 2022	Mar. 31, 2022
Business Combination, Consideration Transferred [Abstract]
Bargain purchase gain		$ 1,665
Pacific Enterprise Bancorp
Business Combination, Consideration Transferred [Abstract]
Stock consideration	$ 64,140
Cash consideration	275
Bargain purchase gain	$ 1,665	$ 1,600

ACQUISITIONS - Pro Forma (Detai

ACQUISITIONS - Pro Forma (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Business Acquisition, Pro Forma Information [Abstract]
Net interest income	$ 23,205	$ 24,271
Net income	$ 1,869	$ 6,084
Basic earnings per share (in dollars per share)	$ 0.14	$ 0.42
Diluted earnings per share (in dollars per share)	$ 0.14	$ 0.42

ACQUISITIONS - Acquisition Expe

ACQUISITIONS - Acquisition Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Business Acquisition [Line Items]
Severance expense	$ 556
Occupancy expense	375
Data processing	1,073
Professional fees	724
Other expenses	347
Total	3,075	$ 0
Pacific Enterprise Bancorp
Business Acquisition [Line Items]
Total	$ 3,100

INVESTMENT SECURITIES - Amortiz

INVESTMENT SECURITIES - Amortized Cost (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	$ 172,927	$ 153,062
Gross unrealized gains	867	3,166
Gross unrealized losses	(5,819)	(570)
Estimated fair value	167,975	155,658
U.S. Government Agencies
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	1,509	1,510
Gross unrealized gains	0	0
Gross unrealized losses	(1)
Estimated fair value	1,508	1,510
Municipal securities
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	23,541	23,646
Gross unrealized gains	56	493
Gross unrealized losses	(1,066)	(16)
Estimated fair value	22,531	24,123
Mortgage-backed securities
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	36,445	33,973
Gross unrealized gains	323	1,333
Gross unrealized losses	(1,474)	(210)
Estimated fair value	35,294	35,096
Collateralized mortgage obligation
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	30,602	27,228
Gross unrealized gains	96	436
Gross unrealized losses	(1,277)	(158)
Estimated fair value	29,421	27,506
SBA securities
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	5,680	6,055
Gross unrealized gains	36	53
Gross unrealized losses	(64)	(20)
Estimated fair value	5,652	6,088
Corporate Bonds
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Amortized Cost	75,150	60,650
Gross unrealized gains	356	851
Gross unrealized losses	(1,937)	(166)
Estimated fair value	$ 73,569	$ 61,335

INVESTMENT SECURITIES - Realize

INVESTMENT SECURITIES - Realized Gains (Details) - security	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Number of available for sale debt securities sold	1	0

INVESTMENT SECURITIES - Estimat

INVESTMENT SECURITIES - Estimated Fair Value and Gross Unrealized Losses (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	$ 104,564	$ 39,340
12 months or more, Estimated fair value	5,775	4,796
Total, Estimated fair value	110,339	44,136
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(5,216)	(401)
12 months or more, Unrealized loss	(603)	(169)
Total, Unrealized loss	(5,819)	(570)
U.S. Government Agencies
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	1,508
12 months or more, Estimated fair value	0
Total, Estimated fair value	1,508
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(1)
12 months or more, Unrealized loss	0
Total, Unrealized loss	(1)
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	14,198	3,932
12 months or more, Estimated fair value	0
Total, Estimated fair value	14,198	3,932
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(1,066)	(16)
12 months or more, Unrealized loss	0
Total, Unrealized loss	(1,066)	(16)
Mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	18,877	2,954
12 months or more, Estimated fair value	2,740	2,133
Total, Estimated fair value	21,617	5,087
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(1,076)	(111)
12 months or more, Unrealized loss	(398)	(99)
Total, Unrealized loss	(1,474)	(210)
Collateralized mortgage obligation
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	18,474	9,236
12 months or more, Estimated fair value	2,059	1,605
Total, Estimated fair value	20,533	10,841
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(1,092)	(108)
12 months or more, Unrealized loss	(185)	(50)
Total, Unrealized loss	(1,277)	(158)
SBA securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	1,194	134
12 months or more, Estimated fair value	976	1,058
Total, Estimated fair value	2,170	1,192
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(44)
12 months or more, Unrealized loss	(20)	(20)
Total, Unrealized loss	(64)	(20)
Corporate Bonds
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, Estimated fair value	50,313	23,084
12 months or more, Estimated fair value	0
Total, Estimated fair value	50,313	23,084
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Less than 12 months, Unrealized loss	(1,937)	(166)
12 months or more, Unrealized loss	0
Total, Unrealized loss	$ (1,937)	$ (166)

INVESTMENT SECURITIES - Unreali

INVESTMENT SECURITIES - Unrealized Loss Positions (Details)	Mar. 31, 2022 security
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions	330
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions	20
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions	145

INVESTMENT SECURITIES - Amort_2

INVESTMENT SECURITIES - Amortized Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Available-for-sale: Amortized Cost
Due in one year or less (remainder of year)	$ 861
Due in one year or less	0	$ 862
Due after one through five years	23,297	23,519
Due after five years through ten years	88,707	79,116
Due after ten years	60,062	49,565
Total	172,927	153,062
Available-for-sale: Fair Value
Due in one year or less (remainder of year)	861
Due in one year or less	0	865
Due after one through five years	23,229	24,173
Due after five years through ten years	85,952	79,993
Due after ten years	57,933	50,627
Total	$ 167,975	$ 155,658

INVESTMENT SECURITIES - Equity

INVESTMENT SECURITIES - Equity Securities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Net loss on equity securities	$ (1,768)
Equity securities	$ 16,698	$ 18,777

LOANS - Loan Portfolio (Details

LOANS - Loan Portfolio (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Loans and Leases Receivable Disclosure [Line Items]
Total loans	$ 2,004,469	$ 1,666,793	$ 1,588,847
Net deferred loan fees	(541)	(1,903)
Allowance for loan losses	(17,700)	(17,700)	(17,500)	$ (17,500)
Net Loans	1,986,228	1,647,190
Commercial Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Total loans	313,556	230,177	323,946
Allowance for loan losses	(3,499)	(3,261)	(3,819)	(4,042)
Construction and Land Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Total loans	20,854	13,371	14,623
Allowance for loan losses	(138)	(175)	(265)	(378)
Commercial Real Estate Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Total loans	1,564,305	1,299,684	1,095,761
Allowance for loan losses	(12,972)	(12,709)	(11,247)	(11,211)
Residential Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Total loans	102,079	118,423	147,685
Allowance for loan losses	(1,073)	(1,536)	(2,147)	(1,856)
Consumer Portfolio Segment
Loans and Leases Receivable Disclosure [Line Items]
Total loans	3,675	5,138	6,832
Allowance for loan losses	$ (18)	$ (19)	$ (22)	$ (13)

LOANS - Impaired Loans (Details

LOANS - Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	$ 7,303		$ 6,604
With a specific allowance recorded	5,925		1,089
Total recorded investment in impaired loans	13,228		7,693
Specific allowance on impaired loans	1,546		930
Average recorded investment in impaired loans	10,440	$ 9,652
Interest recognized	15	63
Commercial Portfolio Segment
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	184		112
With a specific allowance recorded	5,538		681
Total recorded investment in impaired loans	5,722		793
Specific allowance on impaired loans	1,277		681
Average recorded investment in impaired loans	3,237	915
Interest recognized	1	1
Construction and Land Portfolio Segment
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	36		36
With a specific allowance recorded	0		0
Total recorded investment in impaired loans	36		36
Specific allowance on impaired loans	0		0
Average recorded investment in impaired loans	812	36
Interest recognized	0	0
Commercial Real Estate Portfolio Segment
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	5,451		5,015
With a specific allowance recorded	259		262
Total recorded investment in impaired loans	5,710		5,277
Specific allowance on impaired loans	259		224
Average recorded investment in impaired loans	5,493	6,073
Interest recognized	6	58
Residential Portfolio Segment
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	1,632		1,441
With a specific allowance recorded	128		146
Total recorded investment in impaired loans	1,760		1,587
Specific allowance on impaired loans	10		25
Average recorded investment in impaired loans	898	2,628
Interest recognized	8	4
Consumer Portfolio Segment
Financing Receivable, Impaired [Line Items]
With no specific allowance recorded	0		0
With a specific allowance recorded	0		0
Total recorded investment in impaired loans	0		0
Specific allowance on impaired loans	0		$ 0
Average recorded investment in impaired loans	0	0
Interest recognized	$ 0	$ 0

LOANS - Troubled Debt Restructu

LOANS - Troubled Debt Restructurings - General Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Receivables [Abstract]
Financing Receivables, Impaired, Troubled Debt Restructuring, Write-down	$ 0	$ 0
Financing Receivable, Troubled Debt Restructuring, Subsequent Default	0	$ 0
Financing Receivable, TDR Loans, Allowance for Loan Losses	878		$ 31
Loans and Leases Receivable Performing Nonaccrual of Interest	$ 794		$ 805

LOANS - Troubled Debt Restruc_2

LOANS - Troubled Debt Restructurings - Modified as TDR Loans (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) loan	Mar. 31, 2021 USD ($) loan
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Modified Loans, Number | loan	1	2
Financing Receivable, Troubled Debt Restructuring, Loans, Number | loan	8	6
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 7,200	$ 1,601
Extended Maturity [Member]
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 7,200	$ 1,601
Commercial Portfolio Segment
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Loans, Number | loan	3	2
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 4,881	$ 29
Commercial Portfolio Segment | Extended Maturity [Member]
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 4,881	$ 29
Commercial Real Estate Portfolio Segment
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Loans, Number | loan	4	3
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 2,191	$ 1,422
Commercial Real Estate Portfolio Segment | Extended Maturity [Member]
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 2,191	$ 1,422
Residential Portfolio Segment
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Loans, Number | loan	1	1
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 128	$ 150
Residential Portfolio Segment | Extended Maturity [Member]
Financing Receivable, Troubled Debt Restructuring [Line Items]
Financing Receivable, Troubled Debt Restructuring, Modified Loans	$ 128	$ 150

LOANS - Aging (Details)

LOANS - Aging (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Financing Receivable, Past Due [Line Items]
PCD loans	$ 30,897
PCI Loans	30,897	$ 12,219
Total loans	2,004,469	1,666,793	$ 1,588,847
Recorded Investment > 90 Days and Accruing	117	0
Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	13,288	6,989
Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	7,003	1,916
Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	1,475	779
Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	4,810	4,294
PCI Loans	117,000,000	0
Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	1,960,284	1,647,585
Commercial Portfolio Segment
Financing Receivable, Past Due [Line Items]
PCD loans	4,459
PCI Loans	4,459	306
Total loans	313,556	230,177	323,946
Recorded Investment > 90 Days and Accruing	0	0
Commercial Portfolio Segment | Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	6,717	891
Commercial Portfolio Segment | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	5,828	275
Commercial Portfolio Segment | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	236	10
Commercial Portfolio Segment | Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	653	606
Commercial Portfolio Segment | Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	302,380	228,980
Construction and Land Portfolio Segment
Financing Receivable, Past Due [Line Items]
PCD loans	1,447
PCI Loans	1,447	0
Total loans	20,854	13,371	14,623
Recorded Investment > 90 Days and Accruing	0	0
Construction and Land Portfolio Segment | Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	373	374
Construction and Land Portfolio Segment | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	337	0
Construction and Land Portfolio Segment | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	0	338
Construction and Land Portfolio Segment | Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	36	36
Construction and Land Portfolio Segment | Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	19,034	12,997
Commercial Real Estate Portfolio Segment
Financing Receivable, Past Due [Line Items]
PCD loans	23,421
PCI Loans	23,421	10,146
Total loans	1,564,305	1,299,684	1,095,761
Recorded Investment > 90 Days and Accruing	0	0
Commercial Real Estate Portfolio Segment | Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	3,925	3,227
Commercial Real Estate Portfolio Segment | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	109	196
Commercial Real Estate Portfolio Segment | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	697	410
Commercial Real Estate Portfolio Segment | Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	3,119	2,621
Commercial Real Estate Portfolio Segment | Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	1,536,959	1,286,311
Residential Portfolio Segment
Financing Receivable, Past Due [Line Items]
PCD loans	1,570
PCI Loans	1,570	1,767
Total loans	102,079	118,423	147,685
Recorded Investment > 90 Days and Accruing	117	0
Residential Portfolio Segment | Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	2,052	2,494
Residential Portfolio Segment | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	729	1,442
Residential Portfolio Segment | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	321	21
Residential Portfolio Segment | Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	1,002	1,031
Residential Portfolio Segment | Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	98,457	114,162
Consumer Portfolio Segment
Financing Receivable, Past Due [Line Items]
PCI Loans		0
Total loans	3,675	5,138	$ 6,832
Recorded Investment > 90 Days and Accruing	0	0
Consumer Portfolio Segment | Financial Asset, Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	221	3
Consumer Portfolio Segment | Financial Asset, 30 to 59 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	0	3
Consumer Portfolio Segment | Financial Asset, 60 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	221	0
Consumer Portfolio Segment | Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	0	0
Consumer Portfolio Segment | Financial Asset, Not Past Due [Member]
Financing Receivable, Past Due [Line Items]
Loans receivable	$ 3,454	$ 5,135

LOANS - Nonaccrual Loans - Guar

LOANS - Nonaccrual Loans - Guaranteed (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 30,897	$ 12,219
US Government Agency Insured Loans [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 822	$ 841

LOANS - Nonaccrual Loans - Agin

LOANS - Nonaccrual Loans - Aging (Details) $ in Thousands	Mar. 31, 2022 USD ($) loan	Dec. 31, 2021 USD ($)
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 30,897	$ 12,219
Recorded Investment > 90 Days and Accruing	117	0
Commercial Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	4,459	306
Recorded Investment > 90 Days and Accruing	0	0
Construction and Land Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	1,447	0
Recorded Investment > 90 Days and Accruing	0	0
Commercial Real Estate Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	23,421	10,146
Recorded Investment > 90 Days and Accruing	0	0
Residential Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	1,570	1,767
Recorded Investment > 90 Days and Accruing	117	0
Consumer Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual		0
Recorded Investment > 90 Days and Accruing	0	0
Financial Asset, 30 to 89 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	5,600	6,900
Financial Asset, 30 to 89 Days Past Due [Member] | Commercial Portfolio Segment
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 4,900
Financing Receivable, Nonaccrual, Loans, Number | loan	1
Financial Asset, 1 to 29 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 2,200	2,500
Financing Receivable, Nonaccrual, Loans, Number | loan	11
Financial Asset, Equal to or Greater than 90 Days Past Due [Member]
Financing Receivable, Past Due [Line Items]
Financing Receivable, Nonaccrual	$ 117,000,000	$ 0
Financing Receivable, Nonaccrual, Loans, Number | loan	1

LOANS - Nonaccrual Loans - Gene

LOANS - Nonaccrual Loans - General Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Loans and Leases Receivable, Other Information [Abstract]
Loans and Leases Receivable, Impaired, Interest Lost on Nonaccrual Loans	$ 84,600	$ 88,300

ALLOWANCE FOR LOAN LOSSES - Rol

ALLOWANCE FOR LOAN LOSSES - Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	$ 17,700	$ 17,500
Charge-offs	(10)	(2)
Recoveries	3	2
Provision for (reversal of) loan losses	7	0
Ending balance	17,700	17,500
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	3,261	4,042
Charge-offs	0	(2)
Recoveries	3	2
Provision for (reversal of) loan losses	235	(223)
Ending balance	3,499	3,819
Construction and Land Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	175	378
Charge-offs	0	0
Recoveries	0	0
Provision for (reversal of) loan losses	(37)	(113)
Ending balance	138	265
Commercial Real Estate Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	12,709	11,211
Charge-offs	(1)	0
Recoveries	0	0
Provision for (reversal of) loan losses	264	36
Ending balance	12,972	11,247
Residential Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	1,536	1,856
Charge-offs	(6)	0
Recoveries	0	0
Provision for (reversal of) loan losses	(457)	291
Ending balance	1,073	2,147
Consumer Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning balance	19	13
Charge-offs	(3)	0
Recoveries	0	0
Provision for (reversal of) loan losses	2	9
Ending balance	$ 18	$ 22

ALLOWANCE FOR LOAN LOSSES - Add

ALLOWANCE FOR LOAN LOSSES - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	$ 1,664		$ 626
Loans collectively evaluated for impairment	16,036		16,763
Allowance for loan losses	17,700	$ 17,700	17,500	$ 17,500
Individually evaluated	13,228		10,617
Collectively evaluated	1,960,344		1,564,157
Total loans	2,004,469	1,666,793	1,588,847
Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		111
Total loans	30,897		14,073
Commercial Portfolio Segment
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	1,277		490
Loans collectively evaluated for impairment	2,222		3,218
Allowance for loan losses	3,499	3,261	3,819	4,042
Individually evaluated	5,723		978
Collectively evaluated	303,374		322,330
Total loans	313,556	230,177	323,946
Commercial Portfolio Segment | Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		111
Total loans	4,459		638
Construction and Land Portfolio Segment
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	0		0
Loans collectively evaluated for impairment	138		265
Allowance for loan losses	138	175	265	378
Individually evaluated	36		36
Collectively evaluated	19,371		14,539
Total loans	20,854	13,371	14,623
Construction and Land Portfolio Segment | Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		0
Total loans	1,447		48
Commercial Real Estate Portfolio Segment
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	259		116
Loans collectively evaluated for impairment	12,713		11,131
Allowance for loan losses	12,972	12,709	11,247	11,211
Individually evaluated	5,710		6,079
Collectively evaluated	1,535,174		1,078,547
Total loans	1,564,305	1,299,684	1,095,761
Commercial Real Estate Portfolio Segment | Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		0
Total loans	23,421		11,135
Residential Portfolio Segment
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	128		20
Loans collectively evaluated for impairment	945		2,127
Allowance for loan losses	1,073	1,536	2,147	1,856
Individually evaluated	1,759		3,524
Collectively evaluated	98,750		141,909
Total loans	102,079	118,423	147,685
Residential Portfolio Segment | Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		0
Total loans	1,570		2,252
Consumer Portfolio Segment
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Loans individually evaluated for impairment	0		0
Loans collectively evaluated for impairment	18		22
Allowance for loan losses	18	19	22	$ 13
Individually evaluated	0		0
Collectively evaluated	3,675		6,832
Total loans	3,675	$ 5,138	6,832
Consumer Portfolio Segment | Nonperforming Financial Instruments [Member]
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Allowance for loan losses	0		0
Total loans	$ 0		$ 0

ALLOWANCE FOR LOAN LOSSES - Amo

ALLOWANCE FOR LOAN LOSSES - Amortized Cost And Allowance For Credit Losses For Loans On Non-accrual Status (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Total non-accrual	$ 30,897
Commercial Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Total non-accrual	4,459
Construction and Land Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Total non-accrual	1,447
Commercial Real Estate Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Total non-accrual	23,421
Residential Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Total non-accrual	$ 1,570

PREMISES AND EQUIPMENT - Tabula

PREMISES AND EQUIPMENT - Tabular Disclosure (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Less accumulated depreciation and amortization	$ (5,939)	$ (5,454)
Total premises and equipment, net	14,257	14,370
Premises owned
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	11,115	11,015
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	2,619	2,608
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 6,462	$ 6,201

PREMISES AND EQUIPMENT - Deprec

PREMISES AND EQUIPMENT - Depreciation and Amortization (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Depreciation, Depletion and Amortization [Abstract]
Depreciation and amortization included in occupancy and equipment expense	$ 507	$ 502

LEASES - General Information (D

LEASES - General Information (Details)	Mar. 31, 2022 location
Lessee, Lease, Description [Line Items]
Number of offices and branches	34
Noncancelable Operating Leases [Member]
Lessee, Lease, Description [Line Items]
Number of offices and branches	19

LEASES - Maturity (Details)

LEASES - Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
For the remainder of 2023	$ 3,832
2024	3,466
2025	2,952
2026	2,039
2027	1,296
Thereafter	2,563
Total undiscounted cash flows	16,148
Less: interest	(1,971)
Present value of lease payments	$ 14,177	$ 12,657

LEASES - Weighted Average Opera

LEASES - Weighted Average Operating Lease Term and Discount Rate (Details)	Mar. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term	5 years 1 month 6 days
Weighted-average discount rate	2.41%

LEASES - Rental Expense (Detail

LEASES - Rental Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income and Expenses, Lessee [Abstract]
Operating lease expense	$ 1,300	$ 810

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Goodwill [Roll Forward]
Balance at beginning of period	$ 38,838	$ 38,838
Impairment	0	0
Balance at end of period	$ 38,838	$ 38,838

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Changes in Core Deposits (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Finite-lived Intangible Assets [Roll Forward]
Balance at beginning of period	$ 6,489
Less amortization	(495)	$ (454)
Balance at end of period	6,750		$ 6,489
Core Deposits [Member]
Finite-lived Intangible Assets [Roll Forward]
Balance at beginning of period	6,489	$ 8,302	8,302
Additions	756
Less amortization	(495)		(1,813)
Balance at end of period	$ 6,750		$ 6,489

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Estimated Annual Amortization (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
For the remainder of 2023	$ 1,549
2024	1,286
2025	1,222
2026	948
2027	455
Thereafter	1,290
Total	$ 6,750	$ 6,489

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Core Deposit Intangible (Details) - Core Deposits [Member]	3 Months Ended
	Mar. 31, 2022
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	7 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years

INTEREST RECEIVABLE AND OTHER_3

INTEREST RECEIVABLE AND OTHER ASSETS (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Tax assets, net	$ 11,391	$ 10,573
Accrued interest receivable	8,262	5,929
Investment in Small Business Investment Company ("SBIC") fund	4,929	4,731
Investment in Community Reinvestment Act fund	2,000
Prepaid assets	1,076	1,598
Servicing assets	2,365	1,947
Investment in Low Income Housing Tax Credit ("LIHTC") partnerships, net	2,981	3,129
Investment in statutory trusts	485	484
Other assets	5,644	1,469
Total	$ 39,133	$ 29,860

DEPOSITS (Details)

DEPOSITS (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Deposits, by Type [Abstract]
Demand deposits	$ 783,110	$ 710,137
NOW accounts and savings	476,077	484,847
Money market	760,359	568,094
Time deposits	310,849	222,161
Total deposits	$ 2,330,395	$ 1,985,239

BORROWINGS - Federal Home Loan

BORROWINGS - Federal Home Loan Bank (Details) - Federal Home Loan Bank of San Francisco [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank, Advances, Branch of FHLB Bank, Amount of Advances	$ 0	$ 0
Federal Home Loan Bank of San Francisco, Secured Borrowing Facility [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, General Description of Terms	Bank has an approved secured borrowing facility with the Federal Home Loan Bank of San Francisco (the “FHLB”) for up to 25% of total assets for a term not to exceed five years under a blanket lien of certain types of loans.
Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Percentage of Total Assets	25%
Debt Instrument, Term	5 years

BORROWINGS - Federal Funds Line

BORROWINGS - Federal Funds Line - Commitments (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Federal Funds Line, Cumulative Available Commitments [Member]
Other Commitments [Line Items]
Other Commitment	$ 65	$ 65

BORROWINGS - Federal Funds Li_2

BORROWINGS - Federal Funds Line - Outstanding (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Federal Funds Purchased [Member]
Short-term Debt [Line Items]
Short-term Debt	$ 0	$ 0

BORROWINGS - Junior Subordinate

BORROWINGS - Junior Subordinated Deferrable Interest Debentures (Details) - Junior Subordinated Debt [Member] - Floating Rate Junior Subordinated Deferrable Interest Debentures [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt	$ 8.4	$ 8.4
Debt, Weighted Average Interest Rate	3.44%	2.79%
Debt Instrument, Term	30 years

BORROWINGS - SUBORDINATED DEBT

BORROWINGS - SUBORDINATED DEBT (Details) - Subordinated Debt [Member] - Fixed-to-Floating Rate Subordinated Notes, 5.25 Percent, Due 2030 [Member] - USD ($) $ in Millions	Sep. 15, 2025	Mar. 31, 2022	Dec. 31, 2021	Aug. 06, 2020
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 65
Debt Instrument, Interest Rate, Stated Percentage				5.25%
Debt Instrument, Face Amount, Debt Issued, Percentage of Par				100%
Long-term Debt		$ 63.6	$ 63.5
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | Forecast [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	5.21%

INTEREST PAYABLE AND OTHER LI_3

INTEREST PAYABLE AND OTHER LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
Accrued expenses	$ 5,634	$ 7,339
Accounts payable	412	506
Reserve for unfunded commitments	315	315
Accrued interest payable	344	1,180
Other liabilities	3,557	4,516
Total	$ 10,262	$ 13,856

OTHER EXPENSES - Tabular Disclo

OTHER EXPENSES - Tabular Disclosure (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Income and Expenses [Abstract]
Professional fees	$ 1,306	$ 434
Core deposit premium amortization	495	454
Marketing and promotions	296	64
Stationery and supplies	92	107
Insurance (including FDIC premiums)	231	210
Communication and postage	224	214
Loan default related expense	39	14
Director fees	84	76
Bank service charges	66	56
Courier expense	175	176
Other	304	96
Total	$ 3,312	$ 1,901

OTHER EXPENSES - Additional Inf

OTHER EXPENSES - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Income and Expenses [Abstract]
Advertising Expense	$ 21	$ 17

EQUITY INCENTIVE PLANS - Genera

EQUITY INCENTIVE PLANS - General Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			450,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	22,473	24,187
2017 Omnibus Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Annual Stock Grant Limit Per Person, Officers and Employees	50,000
Share-based Compensation Arrangement by Share-based Payment Award, Amount Authorized, Annual Stock Grant Limit Per Person, Officers and Employees	$ 2
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Annual Stock Grant Limit Per Person, Directors	25,000
Common Stock, Capital Shares Reserved for Future Issuance	95,381
2017 Omnibus Equity Incentive Plan [Member] | Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	1 year
2017 Omnibus Equity Incentive Plan [Member] | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period	1 year
2017 Omnibus Equity Incentive Plan [Member] | Minimum | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
2017 Omnibus Equity Incentive Plan [Member] | Maximum | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
2014 Omnibus Equity Incentive Plan [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	1 year
2014 Omnibus Equity Incentive Plan [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
2014 Omnibus Equity Incentive Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	148,962

EQUITY INCENTIVE PLANS - Compen

EQUITY INCENTIVE PLANS - Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement Compensation Expense Items [Abstract]
Stock based compensation expense	$ 324	$ 413

EQUITY INCENTIVE PLANS - Unreco

EQUITY INCENTIVE PLANS - Unrecognized Compensation Cost (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($)
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized [Abstract]
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 1.5
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years

EQUITY INCENTIVE PLANS - Restri

EQUITY INCENTIVE PLANS - Restricted Stock Grant Activity (Details) - Restricted Stock [Member] - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested (in shares)	139,275	204,515
Granted (in shares)	22,473	24,187
Vested (in shares)	(15,560)	(14,164)
Forfeited (in shares)	(532)
Non-vested (in shares)	145,656	214,538
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested (in dollars per share)	$ 16.29	$ 17.71
Granted (in dollars per share)	18.79	15.17
Vested (in dollars per share)	18.34	18.50
Forfeited (in dollars per share)	18.79	0
Non-vested (in dollars per share)	$ 16.45	$ 16.06

FAIR VALUE MEASUREMENT - Recurr

FAIR VALUE MEASUREMENT - Recurring (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	$ 167,975	$ 155,658
U.S. Government Agencies
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	1,508	1,510
Municipal securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	22,531	24,123
Mortgage-backed securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	35,294	35,096
Collateralized mortgage obligation
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	29,421	27,506
SBA securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	5,652	6,088
Corporate Bonds
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	73,569	61,335
Fair Value, Inputs, Level 2 [Member]
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	167,975	155,658
Fair Value, Measurements, Recurring [Member]
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	184,673	174,435
Fair Value, Measurements, Recurring [Member] | U.S. Government Agencies
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	1,508	1,510
Fair Value, Measurements, Recurring [Member] | Municipal securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	22,531	24,123
Fair Value, Measurements, Recurring [Member] | Mortgage-backed securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	35,294	35,096
Fair Value, Measurements, Recurring [Member] | Collateralized mortgage obligation
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	29,421	27,506
Fair Value, Measurements, Recurring [Member] | SBA securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	5,652	6,088
Fair Value, Measurements, Recurring [Member] | Corporate Bonds
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	73,569	61,335
Fair Value, Measurements, Recurring [Member] | Equity Securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	16,698	18,777
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	16,698	18,777
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | U.S. Government Agencies
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Municipal securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Mortgage-backed securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Collateralized mortgage obligation
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | SBA securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Bonds
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	16,698	18,777
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	167,975	155,658
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | U.S. Government Agencies
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	1,508	1,510
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Municipal securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	22,531	24,123
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Mortgage-backed securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	35,294	35,096
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Collateralized mortgage obligation
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	29,421	27,506
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | SBA securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	5,652	6,088
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Bonds
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	73,569	61,335
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0	$ 0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | U.S. Government Agencies
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Municipal securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Mortgage-backed securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Collateralized mortgage obligation
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | SBA securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Corporate Bonds
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Securities
Investments, Fair Value Disclosure [Abstract]
Investment securities available-for-sale (AFS)	$ 0

FAIR VALUE MEASUREMENT - Nonrec

FAIR VALUE MEASUREMENT - Nonrecurring (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	$ 13,228	$ 7,693
Individually evaluated	13,228		$ 10,617
OREO	21	21
Fair Value, Measurements, Nonrecurring [Member]
Assets, Fair Value Disclosure [Abstract]
OREO	21	21
Total	13,249	7,714
Fair Value, Measurements, Nonrecurring [Member] | Performing Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	794	805
Fair Value, Measurements, Nonrecurring [Member] | Nonperforming Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	12,434	6,888
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
OREO	0	0
Total	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 1 [Member] | Performing Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 1 [Member] | Nonperforming Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
OREO	0	0
Total	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 2 [Member] | Performing Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 2 [Member] | Nonperforming Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	0	0
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
OREO	21	21
Total	13,249	7,714
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member] | Performing Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	794	805
Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member] | Nonperforming Financial Instruments [Member]
Assets, Fair Value Disclosure [Abstract]
Impaired Financing Receivable, Recorded Investment	$ 12,434	$ 6,888

FAIR VALUE OF FINANCIAL INSTR_3

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Time deposits in banks	$ 3,336	$ 3,585
Investment securities available-for-sale (AFS)	167,975	155,658
Equity securities	16,698	18,777
Accrued interest receivable	8,262	5,929
Fair Value, Inputs, Level 1 [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents	427,199	379,687
Time deposits in banks	3,336	3,585
Equity securities	16,698	18,777
Investment in FHLB and FRB Stock	19,226	16,035
Fair Value, Inputs, Level 2 [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Investment securities available-for-sale (AFS)	167,975	155,658
Loans held for sale	970	6,470
Accrued interest receivable	8,262	5,929
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits	2,332,443	1,986,651
Accrued interest payable	344	1,180
Fair Value, Inputs, Level 2 [Member] | Fixed-to-Floating Rate Subordinated Notes, 5.25 Percent, Due 2030 [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	63,584	63,542
Fair Value, Inputs, Level 3 [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Loans, net	1,991,792	1,659,811
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Undisbursed loan commitments, lines of credit, standby letters of credit	88,739	103,824
Fair Value, Inputs, Level 3 [Member] | Floating Rate Junior Subordinated Deferrable Interest Debentures [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	8,640	8,612
Reported Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents	427,199	379,687
Time deposits in banks	3,336	3,585
Investment securities available-for-sale (AFS)	167,975	155,658
Equity securities	16,698	18,777
Investment in FHLB and FRB Stock	19,226	16,035
Loans held for sale	970	6,470
Loans, net	1,986,228	1,647,190
Accrued interest receivable	8,262	5,929
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits	2,330,395	1,985,239
Accrued interest payable	344	1,180
Undisbursed loan commitments, lines of credit, standby letters of credit	89,054	104,139
Reported Value Measurement [Member] | Floating Rate Junior Subordinated Deferrable Interest Debentures [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	8,423	8,403
Reported Value Measurement [Member] | Fixed-to-Floating Rate Subordinated Notes, 5.25 Percent, Due 2030 [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	63,584	63,542
Estimate of Fair Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents	427,199	379,687
Time deposits in banks	3,336	3,585
Investment securities available-for-sale (AFS)	167,975	155,658
Equity securities	16,698	18,777
Investment in FHLB and FRB Stock	19,226	16,035
Loans held for sale	970	6,470
Loans, net	1,991,792	1,659,811
Accrued interest receivable	8,262	5,929
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits	2,332,443	1,986,651
Accrued interest payable	344	1,180
Undisbursed loan commitments, lines of credit, standby letters of credit	88,739	103,824
Estimate of Fair Value Measurement [Member] | Floating Rate Junior Subordinated Deferrable Interest Debentures [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	8,640	8,612
Estimate of Fair Value Measurement [Member] | Fixed-to-Floating Rate Subordinated Notes, 5.25 Percent, Due 2030 [Member]
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Debt	$ 63,584	$ 63,542

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Off-balance Sheet Liabilities - Tabular Disclosure (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	$ 89,054	$ 104,139
Commitments to Extend Credit [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	86,292	100,686
Standby Letters of Credit [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	$ 2,762	$ 3,453

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Off-balance Sheet Liabilities - Reserve (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-09, Reserve, Off-balance Sheet Activity [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount	$ 315	$ 315

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Low Income Housing Tax Credit Partnerships [Member]
Other Commitments [Line Items]
Other Commitment	$ 3,200	$ 2,300
Small Business Investment Company [Member]
Other Commitments [Line Items]
Other Commitment	$ 122	$ 122

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES - Deposits (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Concentration Risk [Line Items]
Deposits	$ 2,330,395	$ 1,985,239
Deposits [Member] | Top Ten Depositors [Member]
Concentration Risk [Line Items]
Deposits	$ 265,900	$ 198,600
Deposits [Member] | Deposits [Member] | Top Ten Depositors [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	11.40%	10%

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES - Local Agency Deposits (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Federal Home Loan Bank, Letters of Credit	$ 42	$ 42

LOANS - PCI Loans - Accretable

LOANS - PCI Loans - Accretable Yield - Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Balance at beginning of period	$ 508	$ 383
Additions	1,277	0
Removals	(48)	(65)
Accretion	(50)	(230)
Balance at end of period	$ 1,687	$ 88

LOANS - Risk Grade (Details)

LOANS - Risk Grade (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	$ 2,004,469	$ 1,666,793	$ 1,588,847
Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,926,440	1,614,794
Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	61,688	38,937
Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	16,341	13,062
Commercial Portfolio Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	313,556	230,177	323,946
Commercial Portfolio Segment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	300,516	216,611
Commercial Portfolio Segment | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	3,740	9,178
Commercial Portfolio Segment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	9,300	4,388
Construction and Land Portfolio Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	20,854	13,371	14,623
Construction and Land Portfolio Segment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	17,830	13,264
Construction and Land Portfolio Segment | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	2,988	71
Construction and Land Portfolio Segment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	36	36
Commercial Real Estate Portfolio Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,564,305	1,299,684	1,095,761
Commercial Real Estate Portfolio Segment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,505,699	1,264,269
Commercial Real Estate Portfolio Segment | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	53,433	28,438
Commercial Real Estate Portfolio Segment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	5,173	6,977
Residential Portfolio Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	102,079	118,423	147,685
Residential Portfolio Segment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	98,742	115,534
Residential Portfolio Segment | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,527	1,250
Residential Portfolio Segment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,810	1,639
Consumer Portfolio Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	3,675	5,138	$ 6,832
Consumer Portfolio Segment | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	3,653	5,116
Consumer Portfolio Segment | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	$ 22	$ 22

LOANS - PCI Loans - Unpaid Bala

LOANS - PCI Loans - Unpaid Balance and Carrying Amount (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Impaired Financing Receivable, Unpaid Principal Balance	$ 34,948	$ 14,267
Financing Receivable, Nonaccrual	30,897	12,219
Commercial Portfolio Segment
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Impaired Financing Receivable, Unpaid Principal Balance	5,587	546
Financing Receivable, Nonaccrual	4,459	306
Construction and Land Portfolio Segment
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Impaired Financing Receivable, Unpaid Principal Balance	1,667
Financing Receivable, Nonaccrual	1,447	0
Commercial Real Estate Portfolio Segment
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Impaired Financing Receivable, Unpaid Principal Balance	25,751	11,519
Financing Receivable, Nonaccrual	23,421	10,146
Residential Portfolio Segment
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Impaired Financing Receivable, Unpaid Principal Balance	1,943	2,202
Financing Receivable, Nonaccrual	$ 1,570	1,767
Consumer Portfolio Segment
Impaired Financing Receivable, Unpaid Principal Balance [Abstract]
Financing Receivable, Nonaccrual		$ 0